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ABSTRACT
Background: Leptin, initially believed to simply be a satiety hormone responsible for
obesity, is now recognized as a pleiotropic cytokine that is involved in many biological
processes; including the body’s host inflammatory response. Clinically, leptin may affect
lung function although research in this area is limited. It is also known that the leptin
receptor is necessary for the activation of the leptin protein, making it an important
protein to consider. Furthermore, single nucleotide polymorphisms (SNPs) and DNA
methylations of the leptin and leptin receptor genes (LEP and LEPR respectively) may
provide important insight on the relationship that leptin has with inflammation in the
body.
Objectives: This dissertation focused on: 1) the association between leptin and leptin
receptor gene polymorphisms and lung function (forced vital capacity, FVC; forced
expiratory volume in 1 second, FEV1; and FEV1/FVC) at ages 10 and 18. 2a) The
association between LEP SNPs and LEP DNA methylation. 2b) The association between
LEP DNA methylation and serum leptin levels. 3) The association between leptin and
FVC, FEV1, and FEV1/FVC controlling for body mass index (BMI).
Methods: The Isle of Wight (IOW) birth cohort, a population-based sample of 1,456
infants born between January 1989 and February 1990, was prospectively assessed at
ages 1, 2, 4, 10, and 18 years. FVC, FEV1, and leptin were collected at 10 and 18-year
follow-ups. SNP and DNA methylation data was analyzed from blood that was collected
at birth and 18 years follow up respectively. Regarding associations between LEP and
vii

LEPR SNPs and FVC, FEV1, and FEV1, FVC, forty-two independent repeated
measurement analyses were conducted to test their association. Linear regression
analyses were used to test the links between LEP SNPs and LEP DNA methylation, as
well as the association between LEP DNA methylation and serum leptin protein levels at
age 18. Finally, linear regression analyses were applied to investigate the association
between serum leptin levels at ages 10 and 18 and FVC, FEV1, and FEV1/FVC at ages 10
and 18.
Results: LEPR SNPs rs6669354, rs1137101, and rs3762274 were associated with
decreased lung function from ages 10 to 18. Those with the AC genotype of rs6669354
had 0.092 L lower FVC and 0.10 L lower FEV1 than those with the AA genotype
(Adjusted P-value=0.015 for both tests). A similar pattern was observed for SNPs
rs1137101 and rs3762274 and the association with decreased FEV1/FVC (Adjusted Pvalues 0.04 and 0.02 respectively). LEP SNPs rs11763517 and rs4731429 were both
found to be related with DNA methylation sites cg00666422 (5’UTR region) and
cg24862443 (3’UTR region) and LEP SNP rs4731429 was associated with cg00840332
(TSS200 region). The results were replicated in the second-generation (F2) cohort.
Regarding leptin in F1, increased methylation of cg00840332 interacting with
rs11763517 and rs4731429 was associated with decreased leptin serum levels. Lastly, in
boys, an increase in leptin levels from ages 10 to 18 was related to a 0.017 L decreased
FVC at age 18 (STD=0.007, P-value=0.018), while in girls increased leptin between ages
10 to 18 was associated with FEV1 at age 18 decreasing by 0.013 L (STD=0.006, Pvalue=0.029). These associations were seen even after controlling for BMI.
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Conclusions: LEPR SNPs are associated with decreased FVC, FEV1, and FEV1/FVC
from ages 10 to 18. A possible mechanism for this association can be explained through
the activity of leptin. First, LEP SNPs are associated with increased LEP DNA
methylation at the start of the gene and decreased LEP DNA methylation at the 3’UTR
region of the gene; DNA methylation is linked to circulating serum leptin protein levels.
Second, an increase in leptin protein between the ages of 10 and 18 is associated with
decreased FVC in boys and decreased FEV1 in girls at age 18.
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CHAPTER 1
INTRODUCTION AND LITERATURE REVIEW
1.1 BACKGROUND
Since the cloning of the LEP 1 and LEPR 2 genes and the identification of leptin as
a pleiotropic hormone 3-20, leptin has been the extensive focus of studies regarding
hormone regulation of hunger 21, energy expenditure 4,22, and immune system
homeostasis 5,23-27. Given that weight gain and reduced physical activity in mice was the
most visible response to leptin deficiency and that leptin was found to be expressed and
secreted mainly in white adipose tissue 1,3, it was initially believed that leptin’s primary
role was metabolic. However, it has since been recognized that the adipose tissue is not
inert but rather is an endocrine organ that releases pro-inflammatory and antiinflammatory factors, among them cytokines such as leptin 28. Leptin is now known to
play an important role is the body’s host inflammatory response 5, and by extension, in
the respiratory system 29-35. Leptin is also produced in lower concentrations by other
tissues, namely peripheral lung tissue (bronchial epithelial cells, alveolar type II
pneumocytes, and lung macrophages) 36. There is also evidence that suggests that leptin
plays a key role in lung maturation and development 36,37, that it might be a stimulant of
ventilation 29-35,38, and that it is involved in respiratory diseases (i.e., obstructive sleep
apnea hypopnea syndrome, chronic obstructive pulmonary disease, lung cancer, and
asthma) 37,39-51. It is becoming increasingly clear that the role of leptin in the body’s
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immune response is widespread, complex, and needs to be better understood, especially
in humans.
To start understanding the mechanism behind leptin’s role in the body’s host
inflammatory response and, more specifically, in respiratory illnesses, this dissertation
focused on the association between leptin and leptin receptor gene polymorphisms and
lung function (FVC-forced vital capacity; FEV1-forced expiratory volume in 1 second,
and their ratio FEV1/FVC) while also considering the role of the circulating serum leptin
protein as an intermediary in the above association. These measurements were considered
at two different time points, ages 10 and 18 years of age. FVC, FEV1, and FEV1/FVC
assessments are measured markers that clinicians rely upon to identify asthmatic patients
and are therefore useful in human models. The LEP gene codes for the leptin protein and
is vital in understanding this relationship. However, knowledge of a potential association
between LEP and lung function is currently ambiguous as there are few studies that have
been conducted in humans and those available yield conflicting results. For example, a
single nucleotide polymorphism (SNP) of LEP (rs2167270) has been found to be
associated with FVC and FEV1 52 in one study while another study has found no
association between the same SNP and lower respiratory quotient 53.
Given that leptin activates subsequent processes by binding to the leptin receptor
(LEPR), the LEPR gene also needs to be considered. The leptin receptor is a member of
the class I cytokine receptor super-family and is present in many tissues, including the
lung epithelium 52. A complementary step is to investigate a possible link between LEPR
SNPs and lung function. As with LEP genes, LEPR and LEPROT (leptin receptor
overlapping transcript) genes have not been extensively explored in human populations
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and leave room for further inquiry. Hansel et al found 21 LEPR SNPS to be associated
with FEV1 decline in patients with chronic obstructive pulmonary disease 54 while van
den Borst et al found no association between two LEPR SNPs (that were included in the
21 SNPs from Hansel et al) and FEV1 or FVC 52.
Not only does the association between LEP and LEPR SNPs with lung function
need to be further explored but there needs to also be a better understanding of how the
protein product of these genes influences/mediates this relationship. This involves first
considering a potential association between SNPs and circulating leptin levels and
second, examining a relationship between protein leptin levels and lung function. It is
important to note that plasma leptin levels have been observed to be higher in girls than
boys during and after puberty 55-58. Blum et al found that plasma leptin levels increased in
girls, and decreased in boys after pubertal assessment of Tanner stage 2 and found a
significant gender difference, especially in late puberty and adolescence, even after
adjustment for body mass index (BMI) or body fat percent 55. This is in accordance with
the observation that testosterone inhibits the expression of leptin in the body while
ovarian sex steroids have the opposite effect 55,59,60. Therefore, boys and girls should be
considered separately when evaluating leptin protein levels. It is also important to look at
leptin levels throughout puberty (ages 10 and 18 years in our data) because this is the
period when sex hormone levels fluctuate substantially in boys and girl, thereby
influencing leptin levels.
When investigating the effect of genetic activities on protein leptin levels
additional consideration of DNA methylation can provide a more complete picture. DNA
methylation represents a change in the activity of the gene that does not involve a
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mutation (genetic variation or single nucleotide polymorphism, SNP). This change can be
inherited as a result of past environmental exposures. In a recent article, Yousefi et al
found that that LEPR SNPs in interaction with in utero smoking exposure were
associated with LEPR DNA methylation levels and that LEPR DNA methylation was in
turn associated with serum leptin levels. This two-step analysis revealed that a study of
DNA methylation and genetic variants is more powerful than the single analysis of
genetic variants 61. As part of understanding the mediating effect of circulating body
leptin levels, this dissertation repeated the above-mentioned analysis with LEP SNPs and
LEP DNA methylation and additionally, taking circulating body leptin levels into
account. This investigation provides the needed synthesis of the interplay of SNP, DNA
methylation, and environmental exposures on protein levels that is currently missing in
the literature (briefly mentioned below and explained in more depth in the literature
review).
Depending on the SNP and SNP location, LEP genes have been associated with
increased or decreased protein leptin levels. Fourati et al found that the following LEP
SNPs were associated with elevated plasma leptin levels (hyperleptinemia): rs1349419,
rs12535708, rs10487506, rs11770725, rs12535747, rs7799039, and rs2167270 62. Two
other human studies have found an inverse relationship between LEP SNPs and plasma
and breast tissue leptin levels 63,64. Regarding LEPR SNPs in humans, the LEPR SNP
(rs1137101) and rs17412175 have been shown to be associated with increased leptin
levels in Pacific Islander 65 and English populations 61 respectively, while two other
studies observed no association between genetic variations of the LEPR gene and serum
leptin levels 66,67.
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In a study by Hillemacher et al that looked at 130 men and 34 women 7 days after
alcohol cessation, LEP DNA methylation in the promoter region of the gene was
associated with increasing serum leptin levels in alcohol dependent patients who were
going through withdrawal 68. There is a body of evidence that points to prenatal factors
influencing adult risk of developing various chronic diseases 69. Therefore, it was
important for us to investigate environmental factors that can influence prenatal
conditions. With regard to leptin, there is specific evidence that leptin plays an important
role in prenatal development; LEP methylation has been found to be negatively correlated
with placental gene expression in male infants 70. Given the placenta’s role in controlling
in utero growth and development 71 and there is evidence placental genetic and DNA
methylation profiles may serve as markers of the intrauterine and extra-uterine
environment 72. In addition, studies have found a positive, significant correlation between
leptin levels in cord blood and birth weight 73-75; large for gestational age babies had
higher leptin levels in cord blood compared to appropriate for gestational age babies 75.
To further knowledge on prenatal influences, we considered the in utero environmental
exposure, maternal smoking. Beyond that, genetic variants also have been found to affect
the susceptibility of genes to methylation, a process named allele-specific genotypedependent DNA methylation, or methylation quantitative trait loci methQTL 76-82.
Inconsistent reports on how protein leptin levels are associated with lung function may
now be explained by accumulating evidence that leptin is both a pro-inflammatory and
anti-inflammatory cytokine 83. Leptin contributes to protection from infectious agents but
also to a loss of tolerance and autoimmunity. Reduction in the level of circulating leptin
(from malnutrition or genetic leptin deficiency) results in impaired Th1 response and
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induction of Treg cells, thus reducing the immuno-competence in mice 84 and humans 85
increasing susceptibility to infection. (Th1 helper cells are involved in response against
intracellular parasites). Conversely, a high amount of leptin secreted by adipocytes (from
obesity or genetic leptin receptor deficiency) leads to a high frequency and expansion of
Th1 cells and increased secretion of pro-inflammatory cytokines, on one side, and a low
proportion of proliferation of Treg cells infiltrating adipose tissue, on the other 83. Leptin
is involved with body’s innate and adaptive response and has effects on many cells that
are ultimately related to IL1, IL6, IL-10, IL-1Ra, nitric oxide, LB4, CTA1, COX-2, CD1
1b, IL-1β, IL-8, TNF-α, INF-γ, IL-12, IL-18 and IgG1 86,87.
Contradictory findings on the association between serum leptin levels and lung
function could therefore be due to the fact that leptin signals different immune pathways
depending on its concentration in the body. An example of these contradictory findings
are van den Borst et al not finding an association between serum leptin levels and FEV1 52
while a large middle-age US sample found a relationship between impaired FEV1 and
increased serum leptin levels 88. Hickson et al detected an inverse association between
serum leptin levels and predicted FEV1 and predicted FVC % independent of adiposity
(total body weight, waist circumference, and BMI) in an African American population
women of a normal body weight (the models were also adjusted for age, education,
smoking status, pack-years of cigarette smoking, respiratory medication use, and
menopausal status in women) 89. Childhood lung infection and asthma have also been
related to increased plasma leptin levels, and may be related to maximally attained lung
function 48.
This dissertation investigated 1) an association between LEP and LEPR SNPs with
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FVC, FEV1, and FEV1/FVC in a longitudinal analysis looking at ages 10 and 18 years, 2)
the relationship between LEP and LEPR SNPs and protein leptin levels at age 18,
considering intermediary role of LEP DNA methylation, and 3) the association between
leptin and FVC, FEV1, and FEV1/FVC independent of BMI in concurrent and time delay
models at ages 10 and 18.

1.2 OVERALL DOCUMENT STRUCTURE
This dissertation is divided into the following sections:
i. A literature review (Chapter 1, continuation of current chapter) that summarizes
previous findings investigating the role of leptin in lung function.
ii. A methods section (Chapter 2) that addresses in detail the study methodology for this
work including the statistical procedures that were applied for the data analysis.
iii. A results section (Chapters 3, 4, 5) of three manuscripts, with each chapter comprising
of a journal article that will be submitted to peer‐ reviewed journals for publication.
Manuscript 1. LEPR SNPs are associated with lung function: a longitudinal
analysis
Manuscript 2. LEP SNPs and DNA methylation influence serum leptin levels in
boys and girls: Two-stage model of epigenetic analysis
Manuscript 3. Leptin associated with lung function independent of body mass
index
iv. Finally, a concluding discussion chapter (Chapter 6) that synthesizes the findings from
the three journal articles.
v. The appendices include tables that serve as supplemental material for the articles.
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1.3 LITERATURE REVIEW
1.3.1 BRIEF OVERVIEW OF LEPTIN AND LEPTIN RECEPTOR PROTEINS
Leptin is a 15 kDa protein that consists of 167 amino acids 1. The protein is coded
by the LEP (or ob) gene which is located on chromosome 7 in humans 1. The LEP gene
was first cloned in 1994 at the Jackson Laboratory following the observation of the
random occurrence of mutant mice that weighed three times as much as the wild type
mice 1. These mice had a mutation of what was then named the ob gene that prevented
the functional expression of a protein that is now called leptin. Because of this, leptin was
initially suspected to only play a role in appetite regulation and obesity/adiposity.
While leptin is known to be mainly synthesized and secreted by white adipose
tissue 3, it has also been found in human placenta 90, gastric fundic mucosa in rats 91,
human pancreas 92, fetal baboon lung tissue 93, fetal rat lung fibroblasts94, and in human
peripheral lung tissue (bronchial epithelial cells, alveolar type II pneumocytes, and lung
macrophages) 36,37. The regulation of leptin secretion in the body also appeared to be
straightforward at first. In mouse models, it was observed that food intake lead to
decreased leptin levels while food consumption resulted in transient increases in leptin
expression 21 suggesting leptin’s role as an appetite regulator. This supported the initial
observations mentioned above of leptin deficient mice having greater weight and lower
resting metabolic rate. However, in humans it was observed that obesity was associated
with increased leptin levels, suggesting leptin resistance in the body beyond a certain
weight 95,96 and therefore challenging the previo usly understood linear relationship
between weight and leptin observed in mouse populations. Since its discovery, leptin has
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also been found to play a role in the body’s immune response 5,8-10,12-17,97, stimulation of
insulin secretion and fatty acid oxidation 19, and reduction of cortisol synthesis 20.
The leptin receptor is a member of the class I cytokine receptor super-family and
is coded by the LEPR (or Ob-R) gene 2. Of particular interest for this dissertation is the
expression of the LEPR gene in lung tissue in mice, rats, baboons, and other animals
93,94,98-104

, contributing to the interest of the role of LEPR in human lung function.

Previous findings therefore support the idea that leptin and leptin receptor are
involved with processes in the lung and could be linked to lung diseases such as asthma.
Hence, a logical step is to explore the association of LEP and LEPR genes with lung
function.

1.3.2 LEP AND LEPR SNPS AND LUNG FUNCTION
LEP SNPs (rs2167270, rs13228377, rs2167270) have generally been associated
with lowered respiratory performance. One study in humans found an association
between the A allele of LEP 19 G>A LEP SNP and decreased FEV1 and FVC 52 while
another study found an association between 3’UTR A/G and -2549 A/G LEP SNPs and
asthma 105. Ob/ob (leptin deficient mice) mutant mice were observed to have lower lung
volume and alveolar surface area compared the wild type mice 106. Ob/ob mice also
developed rapid breathing patterns, altered baseline breathing patterns, and depressed
hypercapnic ventilatory response. The latter was present before the mice became obese,
demonstrating deteriorated respiratory control independent of body mass index (BMI).
Total lung capacity and lung compliance were halved in ob/ob mutant mice 32.
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In humans, LEPR gene expression has been observed in human airway smooth
muscle cells 107, epithelial cells, and submucosa of lung tissue obtained by bronchial
biopsies 108. In two human studies, there was no association found between the rs1137100
and rs1137101 LEPR SNPs and lung function and asthma respectively 52,105. Hansel et al
found that 21 LEPR SNPs (rs7531867, rs1805096, rs1892535, rs6588153, rs1938484,
rs12564626, rs10443259, rs6691346, rs4655680, rs1137100, rs6702028, rs1782763,
rs1171265, rs1171271, rs1782754, rs1171274, rs10889558, rs1327121, rs17412682,
rs2025804, rs9436746) were associated with lung function decline in a subset of the Lung
Health Study European Cohort 54.

1.3.3 LEP DNA METHYLATION
Current information on LEP DNA methylation is sparse. The literature shows a
trend for increased DNA methylation in the promoter region correlating with poor health
outcomes. Lesseur et al has found that LEP epigenetic control may be influenced by
perinatal factors. For example, cord blood LEP methylation was found to be higher in
small for gestational age babies and genotypes of rs2167270 LEP SNPs 109. In a
following study by Lesseur et al 70 LEP methylation for placental samples of healthy term
babies showed negative correlation with LEP gene expression, only in male participants.
Higher LEP DNA methylation was also associated with increased lethargy and
hypotonicity, again, only in males in the study. In a small case-control study, mean DNA
methylation of proximal LEP promoter was increased in low birth weight men 110.
Although DNA methylation can be stable throughout one’s life, it can be
modified by environmental factors. Data from the Dutch Famine Birth Cohort have

10

reported higher blood LEP methylation levels in adult men who were prenatally exposed
to war-time famine in 1944-45 compared to unexposed siblings 111. This suggests that an
outside variable may have influenced the LEP DNA methylation. It is therefore valuable
to consider an environmental component in the analysis of the association between
genetic variants, DNA methylation, and leptin concentrations. The specific choice of an
environmental variable for this dissertation is one that is prenatal and influences prenatal
development. During pregnancy the placenta is where maternal exposures, such as
smoking, are translated and can affect fetal programming. Therefore, a variable that
represents the time period of this exposure can provide insight onto how changed in LEP
methylation can affect leptin levels in the body later in life.

1.3.4 PROTEIN LEPTIN LEVELS, IMMUNE RESPONSE, AND LUNG FUNCTION
Leptin’s role in the body’s immune response involves connections between food
intake, metabolism, and immune homeostasis 3,83. The hypothalamic-pituitary-adrenal
(HPA) axis is one of the main structures that is responsible for this connection and this
axis secretes hormones during inflammation to control the body’s immune response.
Leptin and leptin receptor are expressed in the hypothalamus and the pituitary gland
while only the leptin receptor is expressed in the adrenal gland 112. Leptin, in conjunction
with leptin receptor, regulates the secretion of HPA hormones. Studies in mice have
shown that leptin has both a direct and indirect effect on the body’s immunity via the
modulation of central or peripheral pathways 113. Leptin’s role in the body’s immune
response varies depending on how much serum leptin is circulating in the blood. If there
are low amounts of leptin in the body (hypoleptinaemia) then Th1 cells are impaired and
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Treg cells proliferate, leading to increased infections and disease susceptibility
(tuberculosis, candida, pneumonia). If the body has an excess of leptin
(hyperleptinaemia), then Treg cells are inhibited and Th1 cells increase the secretion of
proinflammatory cytokines, leading to increased autoimmune disease susceptibility
(multiple sclerosis, rheumatoid arthritis). When the body has the appropriate moderate
levels of leptin, there is Th1/Th2/Treg balance and the body has an optimal immune
response.
Leptin affects both the body’s innate and adaptive immunity. Studies on human
and animal models have found the following associations between leptin and immune
process in the body. Regarding innate immunity, leptin binds to it receptors in
monocytes, macrophages, neutrophils, eosinophils, dendritic cells, and natural killer cells.
In monocytes and macrophages, leptin is associated with increased phagocytosis and
increased secretion of IL-1, IL-6, and TNFα. It is also linked to increased expression of
activation markers, increased expression of surface markers, and increased eicosanoids,
nitric oxide, leukotriene B4, cholesterol acyltransferase 1, and cyclooxygenase-2. In
neutrophils, leptin seems to increase the formation and release of reactive oxygen species,
increases chemotaxis, decreases apoptosis, and increases the expression of CD1 1b. In
eosinophils, leptin is associated with increased expression of adhesion molecules,
increased chemokinesis, and increased release of IL-1β, IL-6, and IL-8. In dendritic cells,
leptin is associated with increased IL-1β, IL-6, IL-8, IL-12, and TNF-α. Lastly, in natural
killer cells leptin plays a role in increased proliferation and maturation, increase
differentiation activation, and cytoxicity 86.
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When looking at adaptive immune response, human and animal studies have
found that leptin affects thymoctyes, naïve T cells, memory T cells, activates Th1 cells,
inhibits Th2 cells, Treg cells, B cells, and Natural Killer T cells. In thymocytes leptin is
associated with increased maturation and decreases apoptosis 86. In Naïve T cells, leptin
increase proliferation and decreases apoptosis. In memory T cells, leptin binds to its
receptor and decreases proliferation. In Th1 cells activation, leptin increases the IgG2a
switch, increases TNF-α, and increases TNF-γ. During Th2 cell inhibition, leptin
decreases IgG1 switch, and increases secretion of IL-10 5,22. In Treg cells, leptin increases
anergy (absence of immune response), and increases hyperresponsiveness. In B cells,
leptin decreases apoptosis and increases secretion of IL-12, IL-6 and TNF-α. In natural
killer cells, leptin increases proliferation.
Of the cytokines that leptin may affect, IL-10 and IL-12 are available in our
dataset. Furthermore, IL-10 and IL-12 are potentially linked to lung function and asthma,
In a prospective study, IL-10 polymorphisms were associated with obstructive lung
function parameters, suggesting as important role if IL-10 in the development of lung
function deficiency in early bronchitis patients 114. Similarly, a longitudinal study of 379
firefighters with at least six annual FEV1 measurements found that those with IL-10
SNPs had different rates of decline in lung function as they aged 115

Studies in animals have suggested that leptin is involved in respiratory control.
For example, when comparing mutant LEP mice to their wild type counterparts and even
before the onset of obesity, the mutant mice have increased breathing frequency, minute
ventilation and tidal volume, elevated PaCO2 and depressed hypercapnic ventilatory
response 38. Chronic leptin administration restores breathing rates and improves lung
13

compliance. However, because leptin administration in mice also decreases weight, the
improvement of breathing and lung compliance cannot be conclusively attributed to
leptin therapy and not simply a result of lowered body mass index (BMI). Acute leptin
replacement, on the other hand, has led to increased baseline ventilation independent of
weight gain 116, and leptin injections in rat brain has led to increased pulmonary
ventilation and respiratory volume 29,38. Leptin has also been observed to be involved in
the regulation of embryonic lung growth and maturation 106,117. Specifically,
administration of leptin to antenatal mice has led to improved lung development in the
newborn 117, whereas leptin-deficient mice have been observed to have impaired alveolar
formation and lower lung volumes at birth 106. Additionally, postnatal leptin treatment of
these same mice has resulted in increased alveolar surface area and lung volume 106.
Whereas the consensus in animal models is that higher leptin levels are correlated
with improved respiratory response, human studies yield either null findings or an inverse
association. Clinical studies have found that leptin is a predictor of lung function in
asthma patients 35 and is negatively correlated to lung volumes in COPD patients 118 and
clinical severity of asthma 119. Van den Borst et al observed no association between FEV1
and serum leptin levels but found that increased serum leptin levels were associated with
decreased FVC in men but not in women 52. There has also been an observed inverse
association between serum leptin levels and lung function in an African American
population 89 and a twin population 52. Sin et al in a large sample (N=2808) also observed
an inverse association between serum leptin levels and FEV1 and FVC% predicted,
independent of adipocytes in men but found no such pattern in women 88. In a study
involving pre-pubertal boys and girls, increased leptin levels were associated with asthma
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only in boys 48. In an Indian population, increased plasma leptin was associated with
decreased FEV1 but no association was found with FVC.
While sleep apnea cannot be tested from the data available in this study, it is
important to note that the increasing scope of leptin’s influence in the respiratory system
includes the hypothesis that obstructive sleep apnea syndrome (characterized by repeated
episodes of partial or complete upper airway obstruction) is a leptin-resistant state.
Impaired leptin activity in the central nervous system due to a down-regulation of leptin
receptors (54, 76-78) can be responsible for the above hypothesis and is supported by
findings of a LEPR SNP being associated with obstructive sleep apnea syndrome (79) but
not confirmed by another group (80). Patients with untreated asthma have shown
decreased leptin expression in their bronchial epithelium (ex vivo) 108.
Although there is strong evidence that leptin plays a role in the respiratory system,
it is difficult to isolate this role from other factors, such as BMI. Hence there is a need to
control BMI when assessing the risk related to lung function when assessing leptin.
Furthermore, while animal studies show a consistent reaction to leptin levels in the body,
human studies show an opposite effect that may be stratified by sex and endocrine
changes during puberty

1.3.5 GAPS AND LIMITATIONS IN THE CURRENT LITERATURES
- Investigations into the associations between LEP SNPs and lung function only
considered one SNP in the intron region of the gene 52,53. Investigations into the
associations between LEPR SNPs and lung function by Loos et al only looked at SNPs
that consisted of benign missense mutations (mutations that results in genes that code for
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a different amino acid but still express the same protein) and mutations that occurred in
the intron region of the gene53. Only one study has included SNPs that were in the
promoter or 3’ UTR region of the gene or investigated lung function measurements at
multiple time points 54. Lastly, no study has investigated this relationship stratified by sex
or at multiple time points throughout puberty.
- The DNA methylation data used in this dissertation was collected with the
Infinium Human Methylation 450 array, which is reported to have superior
reproducibility and validity than other methods 120,121. Of the studies that investigated an
association between DNA methylation and leptin levels, none used this method of DNA
methylation assessment.
- No studies have analyzed the association between methQTLs and DNA
methylation or employed the two-step analysis for understanding the mechanism behind
an association between LEP SNPs interacting with in utero smoking exposure and serum
leptin levels.
- No studies have explored and association between serum leptin levels and lung
function independent of BMI while stratifying by sex. Given that leptin is inhibited by
testosterone but increased by ovarian sex steroids 5, any analysis involving leptin and
BMI should consider boys and girls separately.
- Studies investigating the association between leptin levels and lung function, do
not take into account the change in leptin levels during puberty 119.

1.4 SPECIFIC AIMS AND HYPOTHESES
This dissertation seeks to enhance our understanding of the association between
LEP and LEPR SNPs and lung function as how this relationship is mediated by leptin.
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Furthermore, this dissertation aimed to demonstrate the LEP SNP leptinlung
function mechanism while taking into consideration the role of epigenetics. In all
analyses, boys and girls were either considered separately or sex was controlled as a
confounder in the models.

Specific Aim 1: The association between LEP and LEPR SNPs and lung function at ages
10 and 18 years.
Hypothesis 1: LEP and LEPR SNPs are associated with lung function measures of FVC,
FEV1, and FEV1/FVC at ages 10 and 18 and this association is gender-specific.

Specific Aim 2: Investigate LEP SNPs that are potential methQTLs interacting with in
utero smoking exposure. DNA methylation sites that are identified in the methQTL
analysis are associated with serum leptin concentrations.
Hypothesis 2a: LEP SNP interacting with in utero smoking exposure is associated with
LEP DNA methylation at age 18 and this association is gender-specific.
Hypothesis 2b: LEP DNA methylation sites found in 2a are associated with protein leptin
levels at age 18 and this association is gender-specific.
We also tested whether hypothesis 2a can be replicated in the subsequent generation of
the Isle of Wight birth cohort (F2-generation).

Specific Aim 3: IL-10 and IL-12 mediate the association of leptin with lung function at
ages 10 and 18.
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Hypothesis 3: Serum leptin levels at ages 10 and 18 are associated with lung function
measures of FVC, FEV1, and FEV1/FVC at ages 10 and 18, using IL-10 and IL-12 as
intervening variables in change models. These associations were stratified by sex.
Theoretical path model:
LeptinIL-10, IL-12FVC, FEV1, FEV1/FVC
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CHAPTER 2
METHODS
2.1 STUDY DESIGN AND PARTICIPANTS
A whole population birth cohort was established on the Isle of Wight, UK, in
1989 to prospectively study the natural history of allergies from birth to 18 years of age.
Ethics approvals were obtained from the Isle of Wight Local Research Ethics Committee
(now the National Research Ethics Service Committee South Central – Southampton B).
Of the 1,536 children born between January 1, 1989, and February 28, 1990, written
informed consent was obtained from parents to enroll 1,456 newborns. Children were
followed up at the ages of 1 (n=1,167), 2 (n=1,174), 4 (n=1,218), 10 (n=1,373), and 18
years (n=1,313). The IOW birth cohort has been described in detail elsewhere 122.
Detailed interviews and examinations were completed for each child at each follow-up.
When a visit was not possible, a telephone questionnaire was completed or a postal
questionnaire was sent. Information on maternal smoking during pregnancy was obtained
from mothers at the time of recruitment (birth).

2.2 LEPTIN CONCENTRATIONS
Leptin concentrations were obtained from blood samples collected at ages 10 and
18 years. Aliquots of blood serum that were isolated from the blood samples were used in
enzyme-linked immunosorbent assays from Biokit, S.A. (Barcelona, Spain). The assays
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were conducted according to the manufacturer’s kit instructions. Each sample, including
standards and the blank, was assayed in duplicate. As part of the repeated follow ups, the
original questionnaire-based information was updated and weight and height of the child
were measured at age 18 years.

2.3 LEP, LEPR, AND LEPROT GENOTYPING AND DNA METHYLATION ANALYSIS
LEP SNPS (k=4) and LEPR SNPs (k=21) that tagged the LEP, LEPR and
neighboring LEPROT genes were identified using Tagger implemented in Haploview.
Leptin receptor overlapping transcript (LEPROT) was included in the analysis because it
shares the same promoter and the first two exons as the LEPR gene. DNA was extracted
from blood or saliva samples from cohort subjects (n=1,211). DNA samples were
interrogated using Golden Gate Genotyping Assays (Illumina Inc, San Diego, CA) on the
Bead Xpress Veracode platform (Illumina, Inc, San Diego, CA) per Illumina’s protocol
120,121

. In brief, samples were fragmented and hybridized to the pool of allele-specific

primer sets. Following an extension/ligation reaction the samples were then hybridized to
the Veracode bead pool and processed on the Bead Xpress reader. Data were analyzed
using the genotyping module of the GenomeStudio Software package (Illumina, Inc, San
Diego, CA). DNA from each subject plus 37 replicate samples were analyzed. The
quality threshold for allele determination was set at a GenCall score 0.25 (scores #0.25
were ‘‘no calls’’) with 98.3% retained for further analysis. Analysis of each locus
included reclustering of genotyping data using our project data to define genotype cluster
positions with additional manual reclustering to maximize both cluster separation and the
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50th percentile of the distribution of the GenCall scores across all genotypes (50% GC
score).
For measuring methylation levels, DNA was extracted from whole blood
collected at age 18 years from 245 female offspring123 as well as 125 males, 100 pregnant
women, and 130 F2 offspring. One microgram of DNA was bisulfite-treated for cytosine
to thymine conversion using the EZ 96-DNA methylation kit (Zymo Research, CA,
USA), following the manufacturer’s standard protocol. Genome-wide DNA-M was
assessed using the Illumina Infinium Human Methylation 450 Bead Chip (Illumina, Inc.,
CA, USA), which interrogates>484,000 CpG sites associated with approximately 24,000
genes. Arrays were processed using a standard protocol as described elsewhere 120, with
multiple identical control samples assigned to each bisulphite conversion batch to assess
assay variability and samples randomly distributed on microarrays to control against
batch effects. The Bead Chips were scanned using a Bead Station, and the methylation
level (beta value) calculated for each queried CpG locus using the Methylation Module of
Bead Studio software.
Concentrations of IL-10 and IL-12 cytokines were measured using the
electrochemiluminescence Meso Scale Delivery (MSD) Kit platform from blood samples
collected at age 18 years (Meso Scale Discovery, Rockville, Maryland, USA), known for
of higher sensitivity, lower level of detection, and wide dynamic range with the standard
curve being linear within the range of experimental samples 124. All experiments were
performed according to the manufacturer’s instructions with minimal modifications and
optimization. Briefly, 50 μl of each 1:2 diluted sample was added to each well of the precoated 96-well plate and incubated at room temperature (RT) for 2.5 h with continuous
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counter-clock-wise shaking. The plates were then washed three times with 1× Wash
Buffer (MSD) and Sulfotag Detection Antibody Cocktail (MSD) was then added to each
well and the plates then incubated for an additional 2 h with shaking at RT. Finally, the
plates were washed again, and were scanned by a SECTOR® Imager 6000 Reader
(MSD) after adding 150 μl of 2× Read Buffer (MSD).

2.4 STATISTICAL ANALYSIS
2.4.1 SA1: HYPOTHESIS 1
LEP and LEPR SNPs are associated with lung function measures of FVC, FEV1,
and FEV1/FVC at ages 10 and 18 and this association is gender-specific.
To identify haplotype blocks, linkage disequilibrium analysis was performed on
fourteen LEPR SNPs and seven LEPROT SNPs with Haploview 4.2 125, using the Gabriel
et al. method 126. We then selected one SNP from each block based on what was
previously chosen in Yousefi et al 61. All four LEP SNPs were tested for their association
with FVC and FEV1 at age 18 years.
Linear mixed models were used to test the association between LEP, LEPR, and
LEPROT SNPs and lung function at ages 10 and 18. With 10 LEPR/LEPROT SNPs and 4
LEP SNPs, and three measures of lung function (FVC, FEV1, and FEV1/FVC) this
resulted in 42 individual tests. Each dependent lung function variable (FVC, FEV1,
FEV1/FVC) was analyzed in a separate model and data from ages 10 and 18 years were
analyzed in the same model. The following variables also had data at both years: age at
follow up, BMI, and height. The full mixed model was controlled for the following
confounders: age at follow up (years), sex (male, female), in utero smoking exposure
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(yes, no), parental asthma status (mother, father, both, or none), ever smoking (yes, no),
SES group (low, middle, high), birth weight (kg), height (cm), BMI (kg/cm2), and
duration of breastfeeding (weeks). An autoregressive covariance structure was used.
Manual backward elimination of confounder applying the 10% rule was used to
determine the most appropriate model.
False discovery rate (FDR) was used to adjust for multiple testing 127. FDR was
applied separately, once with tests involving LEPR and LEPROT SNPs only and another
time looking only at the LEP SNPs.

2.4.2 SA2A: HYPOTHESIS 2A
LEP SNP interacting with in utero smoking exposure is associated with LEP DNA
methylation at age 18 and this association is gender-specific. We will attempt to replicate
this analysis in the F2 population.
Haplotype analysis was performed on LEP SNPs in the F1 and F2 generation of
this cohort (note: Mukherjee et al has performed the analysis in the F1 cohort in a
previous publication that we used in this study as well 128). We used one SNP from each
haplotype block and proceeded with the following analyses.
F1 population: To identify methQTLs modified by gestational maternal smoking,
modeling was performed by using LEP SNPs and their interaction with in utero smoking
exposure to predict the methylation of LEP CpG sites. Each CpG (M-values) was
modeled against rs11763517, rs4731429, and rs10954176, with each SNP interacting
with in utero smoking exposure. In addition, all models were controlled for cellcomposition to ensure that we were indeed observing associations with DNA methylation
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un-confounded by the proportion of these cells. We controlled for levels of the following
cells: B-cells, granulocytes, monocytes, natural killer cells, eosinophils, and CD4 T-cells.
These cell counts were obtained from breast cancer patients from the Winship Cancer
Institute 129, 61 subjects at baseline and 39 subjects at six-month-follow-up. We followed
the method used by Kaushal et al 130 where 484,489 CpG sites were tested against cell
types. The most parsimonious model was determined via backward elimination using the
10% rule, first by removing interaction terms followed by individual SNPs. False
discovery rate was used to adjust for multiple testing.
F2 Population: The methQTL analysis was replicated in the F2 population
(offspring of F1). Eighteen LEP SNPs were genotyped in the F2 population but only 5
SNPs (rs2167270, rs2278815, rs11760956, rs11763517, rs12706832) proved to have
polymorphisms (the others were monomorph, with all or almost all the population having
one of the possible genotypes). Haplotype analysis using Haploview software 125 revealed
that SNPs rs2278815 and rs12706832 were in LD with each other while SNPs
rs11763517 and rs11760956 were in LD with each other (Figure 4.1). Therefore, the
methQTL analysis included the following SNPs interacting with in utero smoking
exposure predicting DNA methylation levels: rs2278815, rs11763517, and rs2167270.
While SNPs in the F1 populations were collected via selected probes, those from the F2
children were from a genome-wide product. Therefore, the following SNPs, rs2167270,
rs2278815, rs11760956, and rs12706832 were not identical with the SNPs identified in
the F1 population. Hence, in order to see if the findings in the F2 population are based on
closely related SNPs, we generated a second LD plot using the International Haplotype
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Map (HapMap) project data from the Central European University database 131 (Figure
4.2).

2.4.3 SA2B: HYPOTHESIS 2B
LEP DNA methylation sites found in 2a are associated with protein leptin levels
at age 18 and this association is gender-specific.
The selected CpG sites (M-values) from hypothesis 2a were tested on whether
they modified the association that LEP SNPs had with leptin serum concentrations at age
18. In this step, our focus was on the interaction effects and false discovery rate was
applied to correct for multiple testing among the tests for interaction effects between CpG
sites and genetic variants. For both sets of statistical analyses, the GLM procedure was
used in SAS 9.4 (SAS, Gary, NC, USA). In addition, because leptin levels vary greatly
between boys and girls following puberty, all models initially controlled for sex. As the
proportion of girls in the subsample with DNA-methylation was higher than the
proportion of boys, the analyses were weighted for sex. Since the same SNP (rs4731429)
that was a methQTL for cg00840332 was also a genetic modifier in the association
between DNA-M and leptin levels, we calculated the residuals from the association
between rs4731429 and cg00840332 using linear regression analyses. These DNAmethylation residuals were then used in testing the association between DNA-M and
leptin levels.
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2.4.4 SA3: HYPOTHESIS 3
Hypothesis 3: Serum leptin levels at ages 10 and 18 are associated with lung
function measures of FVC, FEV1, and FEV1/FVC at ages 10 and 18, using IL-10 and IL12 as intervening variables in change models. These associations are stratified by sex.
Spearman correlations were used to initially check for associations between the
cytokines (IL-10 and IL-12) and leptin at ages 10 and 18 and all lung function measures
at ages 10 and 18. The cytokines were not associated with the exposures or the outcome
so path analysis could not be performed and IL-10 and Il-12 were not used in subsequent
analyses. Linear models were used the test the association between leptin and lung
function (FVC, FEV1, and FEV1/FVC). Two sets of analyses were performed: 1)
Concurrent models tested the association between leptin at age 10 and lung function at
age 10 and leptin at age 10 and lung function at age 18 years. 2) Change in leptin levels
from ages 10 to 18 were employed to predict lung function at age 18 years (time-delayed
model). Since prior findings suggested variations of the associations by the sex of the
child, the subgroup of boys and girls were analyzed separately. In the concurrent models,
we controlled for height and BMI at the respective ages. In the delayed model, we
controlled for height at age 18, change in height between ages 10 and 18, and change in
standardized BMI from ages 10 to 18.
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CHAPTER 3
RESULTS I - MANUSCRIPT #1
LEPR SNPS ARE ASSOCIATED WITH LUNG FUNCTION:
A LONGITUDINAL ANALYSIS1
3.1 INTRODUCTION
Leptin is an extensively studied pleiotropic cytokine that is commonly known for
its association with body mass index (BMI) and energy regulation in the body4,21,22.
However, it is also recognized to play an important role in the body’s host inflammatory
response, although the mechanism is complex and poorly understood 87,132,133.
Specifically, with regards to obstructive lung diseases such as asthma, leptin may
contribute by activating the Janus Kinase 2/Signal Transducer and Activator of Transcript
3 (JAK2/STAT3) signaling pathway 134-139. It has been proposed that the leptin protein
binds to the leptin receptor, enabling the JAK2 to bind to the protein-receptor complex.
This in turn phosphorylates tyrosine residues on the leptin receptor, leading to the
initiation of the JAK2/STAT3 signaling pathway. This pathway subsequently results in
the release of pro-inflammatory cytokines, such as Th1, TNF-α, IFN-γ, IL-2, IL-6, and
IL-12 86, that can lead to airway obstruction diseases. Because of leptin’s involvement

1

M. Yousefi, W. Karmaus, H. Zhang, M Torres, J Burch. LEPR SNPs are associated with lung function: A
longitudinal analysis. To be submitted.
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with immune response, changes in leptin and leptin receptor protein structures (resulting
from genetic variation) may influence respiratory diseases.
Only a few studies have investigated the relationship between LEP SNPs and
respiratory outcomes. Animal studies have observed characteristics in mice that have a
mutation that result in no leptin protein expression (i.e., leptin mutant mice, ob/ob
knockout mice, leptin deficient mice). These mice have been observed to have lower lung
volume and alveolar surface area compared to the wild type mice 106, rapid breathing
patterns, and depressed hypercapnic ventilatory response. The latter has been observed
before the mice became obese, demonstrating deteriorated respiratory control
independent of body mass index (BMI). Total lung capacity and lung compliance are also
halved in ob/ob mutant mice 52. In humans 3’UTR A/G and -2549 A/G LEP SNPs have
been associated with asthma 105.
To date, only two studies have investigated the relationship between LEP SNPs
and lung function specifically. Van den Borst et al found that the AA genotype of
rs2167270 was associated with declined force expiratory volume in one second (FEV1)
and forced vital capacity (FVC) compared to the other genotypes52. Mukherjee et al
found that rs11763517 was associated with decreased FEV1 and FEV1/FVC; however,
only with increased DNA methylation of the LEP gene 128. This study was the first to
explore the longitudinal association between LEP SNPs (rs10249476, rs11763517,
rs4731429, and rs10954176) and FVC, FEV1, FEV1/FVC.
The leptin protein must bind to the leptin receptor to initiate the pathway that is
involved in the body’s host inflammatory response. Therefore, it is important to also
consider the LEPR gene when understanding the role of leptin in the body. Evidence that
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LEPR gene expression has been observed in human airway smooth muscle cells 107,
epithelial cells, and submucosa of lung tissue obtained by bronchial biopsies 108, suggests
that it may play a role in respiratory illnesses. However, in a human study no association
was detected between LEPR SNP rs1137101 and asthma 105. In two human studies, no
association was detected between the rs1137100 and rs1137101 LEPR SNPs and lung
function and asthma respectively 52,105 (Table 3.1). Hansel et al (N=429) found that 21
LEPR SNPs (rs7531867, rs1805096, rs1892535, rs6588153, rs1938484, rs12564626,
rs10443259, rs6691346, rs4655680, rs1137100, rs6702028, rs1782763, rs1171265,
rs1171271, rs1782754, rs1171274, rs10889558, rs1327121, rs17412682, rs2025804,
rs9436746) were associated with lung function decline in a subset of the Lung Health
Study European Cohort 54. However, when looking at two of the same SNPs investigated
by Hansel it al (rs1137100 and rs1137101) , van den Borst et al found no association with
and FEV1 or FVC 52. It is important to note that both studies had a similar sample size
and a longitudinal analysis.
Another gene assisting our understanding in leptin and inflammation is the leptin
receptor overlapping transcript gene, LEPROT. This gene overlaps with the LEPR (as the
name suggests), and aids in cell surface expression of the leptin receptor protein.
When investigating the relationship between LEP, LEPR, and LEPROT SNPs and
lung function, it is important to control for potential confounders. It is well documented
that birthweight is associated with adult lung function. Linear mixed models and path
analysis in a study by Balte et al revealed that increased birthweight was associated with
increased FEV1 and FVC at 18 years of age after adjusting for potential confounders 140.
Other studies have also found a positive linear relationship between birthweight and lung
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function in both adults and children 141-143. Maternal smoking during pregnancy has been
directly associated with FEF25-75 in the Isle of Wight cohort and should therefore be tested
as a potential confounder 140. Height and age are used to predict lung function against
spirometry tests and should therefore be included as well. Likewise body mass index
(BMI) is known to be associated with leptin protein
105,146,147

144,145

, LEP and LEPR genes

, and lung function148. It is known that leptin levels are different between men

and women 55,149,150, so all analyses need to take sex into account. In a previous path
analysis using samples from Isle of Wight cohort that was also analyzed in this work,
duration of breastfeeding was directly positively associated with FVC at age 10 and
indirectly with FVC at age 18 151.
The genetic data from the Isle of Wight Birth Cohort Study 152 provides a unique
opportunity to investigate the relationship between leptin (LEP) and (LEPR) single
nucleotide polymorphisms (SNPs) and lung function. We tested the association of LEP,
LEPROT, and LEPR SNPs with lung function measured by FVC, FEV1, and FEV1/FVC.
FVC quantifies lung volume, FEV1 reveals airway obstruction, and the ratio of
FEV1/FVC shows if there is respiratory distress. In the case of asthma and other
obstructive lung diseases, there is lower than normal FEV1/FVC. This was only the
second study to investigate the relationship between these LEP SNPs and lung function,
and the first to do so in a longitudinal analysis.
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3.2 METHODS
3.2.1 POPULATION CHARACTERISTICS
A whole population birth cohort was established on the Isle of Wight, UK, in
1989 to prospectively study the natural history of allergies from birth to 18 years of age.
Ethics approvals were obtained from the Isle of Wight Local Research Ethics Committee
(now the National Research Ethics Service Committee South Central – Southampton B).
Of the 1,536 children born between January 1,1989, and February 28, 1990, written
informed consent was obtained from parents to enroll 1,456 newborns. Children were
followed up at the ages of 1 (n=1,167), 2 (n=1,174), 4 (n=1,218), 10 (n=1,373), and 18
years (n=1,313). The IOW birth cohort has been described in detail elsewhere 153.
Detailed interviews and examinations were completed for each child at each follow-up.
When a visit was not possible, a telephone questionnaire was completed or a postal
questionnaire was sent. Information on maternal smoking during pregnancy was obtained
from mothers at the time recruitment (birth).

3.2.2 LUNG FUNCTION MEASUREMENTS
FVC and FEV1 were measured at ages 10 and 18 years. Lung function testing
was performed using the Koko spirometry software package on a portable desktop device
(PDS Instrumentation, Louisville, KY, USA) 154. Tests were performed in accordance
with American Thoracic Society and European Respiratory Society spirometry guidelines
6

. Children were required to be free from respiratory infection for 14 days and not taking

systemic oral steroids. In addition, subjects were asked to abstain from any beta-agonist
medication for at least 6 hours and from caffeine intake for at least 4 hours prior to
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testing. Measurements were made in a standardized manner with the subject standing
without a nose clip 155. Forced vital capacity (FVC) was recorded in liters as the best of
three consecutive forced expiratory maneuvers. Participants that exhibited clinical
symptoms consistent with either current infection or a recent (within two weeks) asthma
exacerbation, which required antibiotics or oral steroid within the preceding two weeks,
were rescheduled for spirometry testing.

3.2.3 CONFOUNDERS
We considered the following as potential confounders: age at follow-up, sex, in
utero exposure to maternal smoking, history of parental asthma, birth weight, height at
ages 10 and 18 years, duration of breastfeeding in weeks, if the child ever smoked, and
socioeconomic status (SES).
Age at follow-up was calculated by subtracting date of follow-up from date of
birth. Information on birthweight was obtained from hospital records. Information on
whether the mother smoked while pregnant, parental history of asthma, and the sex of the
child was collected after delivery. Breastfeeding duration was ascertained at ages 1 and 2
years. Socio-economic status was based on three variables: 1) the British socioeconomic
classes (1–6) derived from parental occupation reported at birth; 2) the number of
children in the index child's bedroom (collected at age four years); and 3) family income
at age 10 years. Height and weight were measured before the spirometric tests at age 10
and 18 years. Height was ascertained via the standard height measurement (cm) used at
the allergy clinic for those that visited the center. BMI was calculated. Ever smoking
status was determined by whether the child reported that they currently smoked at age 10
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or 18 follow up or if the child reported to have ever started smoking (even if they no
longer smoked at the follow up times).
The full mixed model was controlled for the following variables: age at follow up
(years), sex (male, female), in utero smoking exposure (yes, no), parental asthma status
(mother, father, both, or none), ever smoking (yes, no), SES group (low, middle, high),
birth weight (kg), height (cm), BMI (kg/cm2), and duration of breastfeeding (weeks).

3.2.4 SNP COLLECTION AND SELECTION
DNA was extracted from blood or saliva samples from cohort subjects (n=1,211).
DNA samples were interrogated using Golden Gate Genotyping Assays (Illumina Inc,
San Diego, CA) on the Bead Xpress Veracode platform (Illumina, Inc, San Diego, CA)
per Illumina’s protocol [45, 46]. In brief, samples were fragmented and hybridized to the
pool of allele-specific primer sets. Following an extension/ligation reaction the samples
were then hybridized to the Veracode bead pool and processed on the Bead Xpress
reader. Data were analyzed using the genotyping module of the GenomeStudio Software
package (Illumina, Inc, San Diego, CA). DNA from each subject plus 37 replicate
samples were analyzed. The quality threshold for allele determination was set at a
GenCall score 0.25 (scores #0.25 were ‘‘no calls’’) with 98.3% retained for further
analysis. Analysis of each locus included reclustering of genotyping data using our
project data to define genotype cluster positions with additional manual reclustering to
maximize both cluster separation and the 50th percentile of the distribution of the
GenCall scores across all genotypes (50% GC score). Reference groups or genotypes
were based on the one that presented the highest frequency.
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All four LEP SNPs were selected to be used in the analysis. To identify haplotype
blocks, linkage disequilibrium analysis was performed on fourteen LEPR SNPs and
seven LEPROT SNPs with Haploview 4.2 125,using the Gabriel et al method 126. This
resulted in the same haplotype blocks found in Yousefi et al 61, so we selected the same
SNPs from each block.

3.2.5 STATISTICAL ANALYSIS
Linear mixed models were used to test the association between LEP, LEPR, and
LEPROT SNPs and lung function at ages 10 and 18. With 10 LEPR/LEPROT SNPs and 4
LEP SNPs, and three measures of lung function (FVC, FEV1, and FEV1/FVC) this
resulted in 42 individual tests. Each dependent lung function variable (FVC, FEV1,
FEV1/FVC) was analyzed in separate model and data from ages 10 and 18 years were
analyzed in the same model. The following variables also had data at both years: age at
follow up, BMI, and height. The full mixed model was controlled for the confounders
mentioned above. An autoregressive covariance structure was used. Manual backward
elimination of confounder applying the 10% rule was used to determine the most
appropriate model. False discovery rate (FDR) was used to adjust for multiple testing 127.
FDR was applied separately, once with tests involving LEPR and LEPROT SNPs only
and another time looking only at the LEP SNPs.

3.3 RESULTS
Of the 1,373 children who followed up at age 10 years, n=981 and n=980,
children had measures on FVC and FEV1, respectively. Of the 1,313 children who
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followed up at age 18 years, FVC and FEV1 were collected on n=838 and n=839
children, respectively (Table 3.2). Height, BMI, FVC, and FEV1 all increased from ages
10 to 18 years. Boys and girls had about the same average FVC and FEV1 at age 10 years
(FVC~2.3 L, FEV1~2.0 L) but at age 18, lung function in boys nearly doubled while that
in girls increased by half the amount (data not shown). At age 18, FVC in boys increased
by 3 L (STD: 0.5) and increased by 1.7 L (STD=0.4) in girls. Similarly, FEV1 in boys
increased by 2.5 L (STD: 0.4) while only increasing by 1.5 L (STD: 0.4) in girls
(stratified data by sex not shown). The FEV1/FVC ratio was the same at both ages (Table
3.2). About a quarter of the children (25.25%) were exposed in utero to maternal
smoking, almost half of the children in the study (45.46%) reported ever having smoked;
9.3 % of mothers and 10.3 % of fathers were reported to have asthma (Table 3.2).
The four LEP SNPs that were examined in this study spanned the length of the
leptin gene, with one in the promoter region (5’UTR), one in the gene’s intron, and two
located in the 3’UTR. In our data, the first LEPROT SNP we have is in the intron region
and is preceded by the LEPR 5’UTR rs3896318 SNP. Two more LEPROT SNPs are in
the intron region, followed by four located in the flanking 3’UTR (Table 3.4). This is
followed by three more LEPR SNPs that are in the promoter region of the gene, three in
the codon region, and six in the intron region. The last LEPR SNP is in the 3’UTR region.
Linkage disequilibrium analysis of the 14 LEPR and 7 LEPROT genes resulted in
5 haplotype blocks and 5 SNPs that did not fit into any blocks (Figure 3.1). SNPs from
the blocks were chosen based on what was used previously by our team 61 and the five
individual SNPs were also considered. These ten SNPs included rs3806318, rs9436740,
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rs9436301, rs17412175, rs6669354, rs7526141, rs12059300, rs1137101, rs3762274, and
rs8179183 (Figure 3.1).
After adjustment for multiple testing via FDR (p-value cut-off of 0.05) 127, linear
mixed models indicated that three SNPs (rs6669354, rs1137101, rs3762274) were
associated with lowered lung function in the repeated measurement analyses (Table 3.5).
In the flanking 3’UTR region of the LEPROT SNP, those with the AC genotype of
rs6669354 had 0.092 L lower FVC and 0.10 L lower FEV1 than those with the AA
genotype (Adjusted P=0.015 for both tests, Table 3.5). Maternal smoking during
pregnancy, whether the child ever smoked, birth weight, duration breastfeeding, and
socioeconomic status did not confound the association. The LEPR SNPs rs1137101 and
rs3762274 were associated with lower FEV1/FVC (Table 3.5). Whether the child smoked
and breastfeeding duration were significant factors in the association between rs1137101
and FEV1/FVC, while breastfeeding duration did not confound the association when
considering the rs3762274 SNP (Table 3.5). None of the LEP SNPs were associated with
FVC, FEV1, or FEV1/FVC (data not shown).
Since sex was a significant confounder in all the models, we investigated
interaction effects of sex and age of follow-up in the four significant models (Table 3.6).
We found that in all the four models, there was a significant difference in the rate of
change in lung function over time between girls and boys. Girls had a lesser increase in
FVC, FEV1, and FEV1/FVC compared to boys (Table 3.6). For example, when
considering rs6669354, girls had an increase in FVC that was -0.090 liters lower than the
increase in FVC in boys. Sex did not mediate the association between any of the LEP
SNPs and any of the lung function values (data not shown). In addition, the child ever
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smoking or duration of breastfeeding also did not mediate the relationship between any of
the LEP SNPs and any of the lung function values.

3.4 DISCUSSION
The findings of this study suggest that single nucleotide polymorphisms (SNPs)
of the leptin receptor play an important role in the body’s lung volume and in airway
obstruction. Our findings agree with Hansel et al that found an association between LEPR
SNPs and lung function decline 54, although they tested different SNPs. Our findings,
however, are not in agreement with van den Borst et al 52 who looked at one of our same
significant LEPR SNPs (rs1137101) and found no association with FEV1 or FVC.
LEPROT and LEPR SNPs were associated with decreased lung function in boys and girls
between ages 10 and 18 years. Lung function increased in both boys and girls with
increased age; however, those with certain genotypes experienced less of an increase. For
example, 207 children with the AC genotype of rs6669354 (19.5% for the SNP) had
lower FVC and FEV1 than those with the AA genotype (Tables 3.4 and 3.5). Likewise,
347 (30.2%) children with AA genotype of rs1137101 and 421 (37.8%) children with AA
genotype of rs3762274 had lower FEV1/FVC than those with the AG genotype.
Furthermore, girls experienced significantly less increase in all lung function measures
when compared to boys. None of the LEP SNPs were associated with lung function.
The leptin receptor protein is known to exist in six isoforms, LEPRa, LEPRb,
LEPRc, LEPRd, LEPRe, and LEPRf. LEPRb is the 156 is the long form of the leptin
receptor and is the one that the leptin protein attaches to and starts the JAK/STAT
pathway that is involved in inflammation. It is not possible while looking at just LEPR
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SNPs, to determine what splicing will occur, subsequently resulting in the different forms
of the leptin receptor. For this reason, it would be valuable also to consider the leptin
receptor protein.
There were no differences between the whole population cohort and the sample
used in this analysis when considering the confounding variables (Table 3.3). However,
there was a significant difference in missing data in the follow-up data for socioeconomic
status, maternal smoking during pregnancy, and whether the child ever smoked. The
proportion of missing data is lower in the samples with lung function, hence it is unlikely
that a non-response bias affected the analyses of the data. The significant difference in
the missing data suggests that those who did not provide information on socioeconomic
status, maternal smoking during pregnancy, and whether the child ever smoked, were
also less likely to follow up with their lung function measurements later in the study.
FVC and FEV1 were collected under standard clinic conditions at ages 10 and 18-year
visits, reducing the possibility for information bias. Due to the link between leptin and
body mass index (BMI), we tested that BMI at ages 10 and 18 and the SNPs were not
associated (Appendix A).
Understanding leptin’s role in the body is difficult because the protein is involved
in both the pro-inflammatory and anti-inflammatory response. Leptin up-regulates the
expression of pro-inflammatory cytokines, such as TNF-α, IL-6, and IL-12 86,157, but also
increases chemotaxis and natural killer cell functions 83. The observed association
between mutations at the coding and intron region of the LEPR gene being associated
with lower FEV1/FVC, suggest that these SNPs may affect the body’s pro-inflammatory
response. Leptin has to bind to its receptor in order to start the chain of events that lead
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the body’s secretion of various cytokines 134,135,137,138,158. An illuminating step would be
to explore associations between these LEPR and LEPROT SNPs and the cytokines in the
JAK-STAT pathway.

3.5 CONCLUSION
Our findings show that the LEPROT SNP rs6669354 and the LEPR SNPs
rs1137101 and rs3762274 are associated with decreased lung function and that between
the ages of 10 and 18 years, girls experience a smaller increase in lung function that boys.
However, no difference was found between the SNP-lung function association between
boys and girls. This shows the differences observed between the sexes in leptin and lung
function between the ages of 10 and 18 may not be explained on the genetic level. It
would be valuable to look directly at protein leptin receptor. It could also be important to
consider associated between these LEPROT and LEPR SNPs and cytokines involved in
the JAK/STAT pathway. Lastly, in our data LEP SNPs were not found to be associated
with lung function values, suggesting that LEPR SNPs play a more important role in lung
function.
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Table 3.1. Literature review of associations between SNPs in this study and lung function
LEPR SNP

rs8179183

rs1137100

Article

Findings

Hansel, N.N., et al., Leptin receptor polymorphisms and lung function
decline in COPD. Eur Respir J, 2009. 34(1): p. 103-10.

Associated with reduced FEV1.

Loos, R.J., et al., Polymorphisms in the leptin and leptin receptor genes Homozygote had a lower respiratory
in relation to resting metabolic rate and respiratory quotient in the
quotient than the other genotypes.
Quebec Family Study. Int J Obes (Lond), 2006. 30(1): p. 183-90.
van den Borst, B., et al., Genetics of maximally attained lung function:
a role for leptin? Respir Med, 2012. 106(2): p. 235-42.

No association found with FEV1 or FVC.

Hansel, N.N., et al., Leptin receptor polymorphisms and lung function
decline in COPD. Eur Respir J, 2009. 34(1): p. 103-10.

Associated with reduced FEV1.
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Loos, R.J., et al., Polymorphisms in the leptin and leptin receptor genes Homozygote had a lower respiratory
in relation to resting metabolic rate and respiratory quotient in the
quotient than the other genotypes.
Quebec Family Study. Int J Obes (Lond), 2006. 30(1): p. 183-90.
rs1137101

van den Borst, B., et al., Genetics of maximally attained lung function:
a role for leptin? Respir Med, 2012. 106(2): p. 235-42.

No association found with FEV1 or FVC.

rs1782754

Hansel, N.N., et al., Leptin receptor polymorphisms and lung function
decline in COPD. Eur Respir J, 2009. 34(1): p. 103-10.

Associated with reduced FEV1 in COPD
patients.

rs3828934

Hansel, N.N., et al., Leptin receptor polymorphisms and lung function
decline in COPD. Eur Respir J, 2009. 34(1): p. 103-10.

Associated with reduced FEV1 in COPD
patients.

Table 3.2. Population Characteristics
Variable
Birth weight (kg)
Duration breastfeeding (weeks)
FVC at age 10 (L)
FVC at age 18 (L)
FEV1 at age 10 (L)
FEV1 at age 18 (L)
FEV1/FVC at age 10
FEV1/FVC at age 18
Height at age 10 (cm)
Height at age 18 (cm)
BMI at age 10 (kg/m2)
BMI at age 18 (kg/m2)
Age at 10-year follow up (years)
Age at 18-year follow up (years)
Sex
Socio-economic status

Parental asthma status

In utero smoking exposure
Child ever smoked

N
1511
1345
981
838
980
839
980
839
1043
994
1043
964
1536
1255

Mean
3.39
14.28
2.29
4.61
2.03
4.01
0.89
0.87
138.93
171.21
18.11
23.19
10.02
17.91
N
Male
786
Female 750
High
111
Mid
1037
Low
209
None
1208
Father 140
Mother 155
Yes
384
Yes
581
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Median
3.41
8.00
2.28
4.47
2.01
3.91
0.89
0.88
138.70
171.00
17.35
22.15
10.00
17.72
%
51.17
48.83
8.18
76.42
15.40
80.37
9.31
10.31
25.25
45.46

p5, p95
2.57, 4.20
0.00, 40.00
1.76, 2.88
3.22, 6.28
1.58, 2.56
2.85, 5.41
0.79, 0.97
0.75, 0.98
129.10, 149.50
156.50, 187.00
14.71, 23.95
18.20, 32.14
9.57, 10.55
17.17, 19.13

Table 3.3 Whole population cohort vs. sample with lung function data at ages 10 or 18

Whole Cohort
Variable
Birth weight (kg)

N, Mean; STD
1511, 3.39; 0.54
Missing 25
Duration breastfeeding
1345, 14.28; 14.8
(weeks)
Missing 191
Height at age 10 (cm)
1043, 138.93; 6.18
Missing 493
Height at age 18 (cm)
994, 171.21; 9.45
Missing 542
BMI at age 10 (kg/m2)
1043, 18.11; 2.98

Sample with
FEV1 data at
ages 10 or 18
years
N, Mean, STD
1102, 3.41, 0.51
18
1031, 15.08,
14.96
89
1025, 138.90,
6.16
95
918, 170.98,
9.30
202
1025, 18.12,
2.98
95
896, 23.21, 4,33
224
N(%)
557 (49.73)
563 (50.27)
85 (7.59)
849 (75.80)

P-Value
0.34
0.19

1.00

1.00

1.00

Missing 493
BMI at age 18 (kg/m2)
964, 23.19; 4.33
0.92
Missing 572
N (%)
Sex
Male
786 (51.17)
0.48
Female
750 (48.83)
<.0000001*
Socio-economic status
High
111 (7.23)
Mid
1037
(67.51)
Low
209 (13.61) 160 (14.29)
Missing 179 (11.65) 26 (2.32)
0.37
Parental asthma status
None
1208
892 (79.64)
(78.65)
Father
140 (9.11)
104 (9.20)
Mother 155 (10.09) 110 (9.82)
Missing 33 (2.15)
15 (1.34)
In utero smoking
Yes
384 (25.00) 253 (22.59)
0.05*
exposure
Missing 15 (0.98)
4 (0.36)
<.0000001*
Child ever smoked
Yes
581 (37.83) 449 (40.09)
Missing 258 (16.80) 93 (8.30)
*This significant difference is due to differences in frequency of missing data for these
variables, not differences between the other groups.
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Table 3.4: LEP, LEPR, and LEPROT SNP characteristics
Gene

SNP

LEP

rs10249476

LEP

rs11763517

LEP

rs4731429

LEP

rs10954176

LEPR

rs3806318

LEPROT

rs9436738

LEPROT

rs9436740

LEPROT

rs9436301

LEPROT

rs17412175

LEPROT

rs9436747

LEPROT

rs9436748

LEPROT

rs6669354

LEPR

rs7526141

Genotype
AA
AC
CC
AA
AG
GG
AA
AG
GG
AA
AG
GG
AA
AG
GG
AA
AG
GG
AA
AT
TT
AA
AG
GG
AA
AT
TT
AA
AG
GG
AA
AC
CC
AA
AC
CC
AA
AG

N (%)
156 (13.55)
542 (47.09)
453 (39.36)
293 (25.46)
569 (49.44)
289 (25.11)
238 (20.66)
582 (50.52)
332 (28.82)
338 (29.57)
534 (46.72)
271 (23.71)
580 (50.88)
465 (40.79)
95 (8.33)
10 (0.86)
241 (20.81)
907 (78.32)
101 (8.83)
446 (38.99)
597 (52.19)
658 (57.17)
431 (37.45)
62 (5.39)
243 (21.11)
560 (48.65)
348 (30.23)
175 (15.07)
512 (44.10)
474 (40.83)
214 (18.71)
556 (48.60)
374 (32.69)
836 (78.65)
207 (19.47)
20 (1.88)
256 (22.20)
556 (48.22)
43

Location

Coordinate

Flanking_5UTR

128236973

Intron

128250009

Flanking_3UTR

128263486

Flanking_3UTR

128267266

Flanking 5’UTR

65885357

Intron

65888560

Intron

65891901

Intron

65895927

Flanking 3’UTR

65904886

Flanking 3’UTR

65911607

Flanking 3’UTR

65911672

Flanking 3’UTR

65925349

Flanking 5’UTR

65975275

LEPR

rs1171275

LEPR

rs1782754

LEPR

rs1137100

LEPR

rs3790424

LEPR

rs10493380

LEPR

rs12059300

LEPR

rs1137101

LEPR

rs3828034

LEPR

rs3762274

LEPR

rs8179183

LEPR

rs6678033

LEPR

rs17415296

GG
AA
AG
GG
AA
AG
GG
AA
AG
GG
AA
AG
GG
AA
AC
CC
AA
AG
GG
AA
AG
GG
AA
AG
GG
AA
AG
GG
CC
CG
GG
AA
AG
GG
AA
AC
CC

341 (29.58)
32 (2.78)
334 (29.04)
784 (68.17)
590 (50.82)
473 (40.74)
98 (8.44)
592 (51.30)
465 (40.29)
97 (8.41)
580 (50.70)
457 (39.95)
107 (9.35)
791 (69.45)
317 (27.83)
31 (2.72)
37 (3.20)
378 (32.70)
741 (64.10)
347 (30.15)
558 (48.48)
246 (21.37)
777 (67.80)
330 (28.80)
39 (3.40)
421 (37.83)
525 (47.17)
167 (15.00)
37 (3.23)
320 (27.97)
787 (68.79)
159 (13.96)
533 (46.80)
447 (39.24)
38 (3.27)
332 (28.55)
793 (68.19)
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Flanking 5’UTR

65982633

Flanking 5’UTR

65993348

Coding

66036441

Intron

66044013

Intron

66046117

Intron

66047072

Coding

66058513

Intron

66062325

Intron

66064113

Coding

66075952

Intron

66077624

3’ UTR

66099013

Table 3.5. LEPR and LEPROT SNPs associated with lung function measures
Associated with FVC (Liters)
Variable
Genotype Estimate
Standard
F-test PFDR adjusted
Error
value
P-value
a
rs6669354
AC
-0.092
0.028
CC
0.16
0.097
0.0010
0.01500
AA
REF
REF
Associated with FEV1 (Liters)
Variable
Genotype Estimate
Standard
F-test PFDR adjusted
Error
value
P-value
b
rs6669354
AC
-0.10
0.026
CC
-0.021
0.090
0.0007
0.01500
AA
REF
REF
Associated with FEV1/FVC (Liters)
Variable
Genotype Estimate
Standard
F-test PFDR adjusted
Error
value
P-value
c
rs1137101
AA
-0.012
0.0046
GG
0.0053
0.0051
0.0055
0.04125
AG
REF
REF
d
rs3762274
AA
-0.013
0.0042
GG
0.0031
0.0057
0.0024
0.02400
AG
REF
REF
a, b: Controlled for age at each follow up, sex, height at ages 10 and 18, and BMI at ages
10 and 18.
c: Controlled for age at each follow up, sex, whether the child ever smoked, height and
BMI at ages 10 and 18, and the duration of breastfeeding.
d: Controlled for age at each follow up, sex, whether the child ever smoked, and height
and BMI at ages 10 and 18.

45

Table 3.6. Interaction effect of sex and age of follow up on lung function measures

Variable

Model 1

a

rs6669354

Age at
follow up
(years)
Sex
Female vs.
Male
Age*Sex
(Female vs.
Male)
Model 2

b

rs6669354

Age at
follow up
(years)
Sex
Female vs.
Male
Age*Sex
(Female vs.
Male)
Model 3

c

rs1137101

Age at
follow up
(years)

Genotype Estimate

Standard
Error

F-test Pvalue

FDR
adjusted Pvalue

Associated with FVC (Liters)
AC vs
-0.098
0.027
AA
0.00017
CC vs
0.18
0.093
AA
0.15
0.0085
<0.0000001

0.76

0.065

<0.0000001

-0.090

0.0045

<0.0000001

<0.0000001

Associated with FEV1 (Liters)
AC vs
-0.11
0.025
AA
0.0001
CC vs
-0.0020 0.086
AA
0.13
0.0077
<0.0000001

0.71

0.058

<0.0000001

-0.078

0.0044

<0.0000001

Associated with FEV1/FVC (Liters)
AA vs
-0.012
0.0046
AG
0.0041
GG vs
0.0053
0.0051
AG
0.0032
0.0014
0.0483
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<0.0000001

Model 4

Sex
Female vs.
Male
Age*Sex
(Female vs.
Male)
rs3762274d

AA vs
AG
GG vs
AG

0.037

0.010

0.0004

-0.0018

0.00077

0.0199

-0.013

0.0042

0.0027

0.0057

0.0199

0.0017

Age at
0.0037
0.0014
0.0166
follow up
(years)
Sex
0.037
0.010
0.0003
Female vs.
Male
Age*Sex
-0.0019 0.00075
0.0127
0.0199
(Female vs.
Male)
a, b: Also controlled for height at ages 10 and 18, and BMI at ages 10 and 18.
c: Also controlled for whether the child ever smoked, height and BMI at ages 10 and 18,
and the duration of breastfeeding.
d: Also controlled for whether the child ever smoked, and height and BMI at ages 10 and
18.
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Figure 3.1 Haplotype analysis of LEPR and LEPROT genes (r2)
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CHAPTER 4
RESULTS II – MANUSCRIPT #2
LEP SNPS AND DNA METHYLATION INFLUENCE SERUM LEPTIN LEVELS IN
BOYS AND GIRLS: TWO-STAGE MODEL OF EPIGENETIC ANALYSIS2
4.1 INTRODUCTION
Leptin is a 16kDa pleiotropic cytokine that plays a role in many physiological
processes in the body 159-162 and is intimately linked to the body’s host inflammatory
response 132,133,163. The levels of circulating leptin in the body affect subsequent
biological pathways. For example, with moderate leptin levels Th1/Th2/Treg cells are in
equilibrium indicating an optimal immune response. However, when the body has low
amounts of leptin (hypoleptinaemia), Th1 cells are impaired and Treg cells proliferate,
leading to suppressed immune response and increased infections and disease
susceptibility (such as tuberculosis, candida, and pneumonia). If the body has an excess
of leptin (hyperleptinaemia), Treg cells are reduced and Th2 cells increase secretion of
proinflammatory cytokines, which can influence obstructive lung diseases such as asthma
5,22

. It is therefore important to understand what factors can influence leptin levels in the

body.
Genetic variations in the leptin gene have been associated with protein leptin
levels. Numerous candidate gene studies looking at single nucleotide polymorphisms
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(SNPs) have detected associations between G-2548A (also known as rs7799039, located
in the promoter region of the gene) and decreased leptin levels 164-169. Conversely,
Fourati et al found that two LEP SNPs in the promoter region of the gene (H1328084 and
A19G) were associated with increased leptin levels 62. In a genome-wide meta-analysis,
questions arose about the association of LEP SNPs with circulating leptin levels. The
LEP SNP, rs10487505 (located in the intron region), was associated with decreased leptin
levels, but was not associated with LEP messenger RNA expression in the omental or
subcutaneous adipose tissue, liver, lymphocytes, or the brain. This suggested that other
mechanisms may be at play in mediating the association between LEP SNPs and leptin
levels 170.
A possible such mediator (and effect modifier) could be DNA methylation of LEP
gene, which may influence the expression of leptin protein. Few studies have looked at
DNA methylation in the leptin gene and only one study has investigated the association
between LEP DNA methylation and leptin protein levels. Hillemacher et al found that
LEP DNA methylation in the promoter region of the gene was associated with increasing
serum leptin levels in alcohol dependent patients who were going through withdrawal 68.
Since the process of DNA methylation begins in utero, it is helpful to look at
environmental exposures that occur during pregnancy. In a previous study using data
from the Isle of Wight birth cohort study, the interaction between maternal smoking
during pregnancy and leptin receptor (LEPR) SNPs was associated with DNA
methylation in the offspring 61. We followed the same analytical steps using LEP SNPs
and LEP DNA methylation levels. Specifically, we used data from the Isle of Wight Birth
Cohort Study to investigate a two-stage explanatory model: First, LEP SNPs have the
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potential to constitute methylation quantitative trait loci (methQTLs), i.e., specific
genotypes of SNPs may influence the susceptibility of specific gene loci to change the
level of DNA-methylation. In addition, this susceptibility may be modified by
environmental exposures. Thus, SNPs may interact, for instance, with in utero smoking
exposure. Second, we tested to see if the DNA methylation sites (CpG sites: locations on
a DNA sequence where hydrogen groups are replaced with a methyl group) that are
identified as being related to methQTLs were associated with serum leptin concentrations
at age 18 years. We also examined whether the methQTLs findings could be replicated in
the F2 population of the three generation Isle of Wight birth cohort. This was the first
study to test the association of LEP methylation sites with LEP SNPs and leptin protein
levels.

4.2 METHODS
4.2.1 STUDY POPULATION AND CHARACTERISTICS
4.2.1A F1 POPULATION
Between January 1989 and February 1990, 1536 F1-children born on the Isle of
Wight (IOW), UK were recruited and interviewed with 1456 available for further followup in a longitudinal study. The local research ethics committee approved the study and
informed written parental consent was obtained from all participants at recruitment and
subsequently at each follow-up. The IOW birth cohort has been described in detail
elsewhere 61,152. Briefly, upon delivery, birth weight was measured and data from birth
records and questionnaires were collected, including information on maternal smoking
during pregnancy. Children were followed up at the ages of 1 (n=1167, 80.2%), 2
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(n=1174, 80.6%), 4 (n=1218, 83.7%), 10 (n=1373, 94.3%) and 18 years (n=1313,
90.2%). Data was collected at each follow up time via interviews and examinations.
When a visit was not possible, a telephone questionnaire was completed or a postal
questionnaire was sent. Information on maternal smoking during pregnancy was obtained
from mothers at the time of birth.
Leptin concentrations were obtained from blood samples collected from F1children at age 18 years. Aliquots of blood serum isolated from the blood samples were
used in enzyme-linked immunosorbent assays from Biokit, S.A. (Barcelona, Spain). The
assays were conducted according to the manufacturer’s kit instructions. Each sample,
including standards and the blank, was assayed in duplicate.
DNA was extracted from blood or saliva samples from cohort subjects (n=1,211).
Details of the procedure have been described elsewhere 61,171. Four LEP SNPs
(rs4731429, rs10249476 rs10954176, and rs11763517) were genotyped in the F1
population. For measuring methylation levels, DNA was extracted from whole blood
collected at age 18 years from 245 female offspring and 125 male offspring. DNA was
extracted from peripheral blood samples collected from the F1 generation at age 18,
during pregnancy, and from cord blood of F2 at birth. DNA methylation levels were
measured using the Illumina 450K platform and quantified using β values that present the
proportion of methylated (M) over the sum of methylated and unmethylated (U) allele
intensities (β=M/ [c+M+U]), where c is a constant to prevent zero in the denominator 172.
The β values were employed as predictors of asthma or wheezing; however, for
methylation analysis we used M-values (logit-transformed β values) as the response
variable since β values are often heteroscedastic.173
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4.2.1B F2 POPULATION
These F1 participants themselves became pregnant or fathered a child, who was
then enrolled in a follow-up study. Cord blood was collected from the F2-offspring for
DNA methylation; however, cord blood samples could not be collected in all deliveries.
SNPs in the F2 generation were genotyped on Illumina's HumanOmniExpressExome
beadchip (v1.2) for more than 960k loci. Arrays were processed at the Wellcome Trust
Centre for Human Genetics (Oxford, UK). Genotypes were extracted from image data
using GenomeStudio software (Illumina). SNPs located in or near IL1RL1 were
identified using the Illumina annotations from the genotyping chip's annotation file
(available at: http://support.illumina.com/downloads/humanomniexpressexome-8v12_product_support_files.html).

4.2.2 STATISTICAL ANALYSIS
4.2.2A F1 POPULATION
Haplotype analysis performed on the LEP SNPs in the F1 generation of this
cohort in a previous study by Mukherjee et al 128 showed that two of the SNPs present in
the F1 generation data had been in LD with each other: rs10249476 and rs11763517.
Therefore, in our analysis involving LEP SNPs in the F1 generation we included:
rs11763517, rs4731429, and rs10954176.
After cleaning the DNA-M data, beta (β) values were presented as the proportion
of methylated (M) over methylated (M) and unmethylated (U) sites (β=M/[c+M+U], with
c being constant to prevent dividing by zero) were used to estimate the effect of DNA-M
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[51]. M-values were then calculated using the logit-transformed β values (log2β /(1-β )).
The M-values of the methylation of seven CpG sites (six at the start and one at the end of
the LEP gene) were analyzed in this study.
In Stage 1, to identify methQTLs modified by gestational maternal smoking,
modeling was performed by using LEP SNPs and their interaction with in utero smoking
exposure to predict the methylation of LEP CpG sites. Each CpG (M-values) was
modeled against rs11763517, rs4731429, and rs10954176, with each SNP interacting
with in utero smoking exposure. In addition, all models were controlled for cellcomposition to ensure that we were indeed observing associations with DNA methylation
un-confounded by the proportion of these cells. We controlled for levels of the following
cells: b cells, granulocytes, monocytes, natural killer cells, eosinophils, and CD4 T-cells.
These cell counts were obtained from breast cancer patients from the Winship Cancer
Institute 129, 61 subjects at baseline and 39 subjects at six-month-follow-up. We followed
the method used by Kaushal et al 130 where 484,489 CpG sites were tested against cell
types. The most parsimonious model was determined via backward elimination using the
10% rule, first by removing interaction terms followed by individual SNPs. False
discovery rate was used to adjust for multiple testing.
Stage 2: Next, the selected CpG sites (M-values) were tested on whether they
modified the association that LEP SNPs had with leptin serum concentrations at age 18.
In this step, our focus was on the interaction effects and false discovery rate was applied
to correct for multiple testing among the tests for interaction effects between CpG sites
and genetic variants. For both sets of statistical analyses, the GLM procedure was used in
SAS 9.4 (SAS, Gary, NC, USA). In addition, because leptin levels vary greatly between
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boys and girls following puberty, all models initially controlled for sex as well. As the
proportion of girls in the subsample with DNA-methylation was higher than the
proportion of, the analyses were weighted for sex. Since the same SNP (rs4731429) that
was a methQTL for cg00840332 was also a genetic modifier in the association between
DNA-M and leptin levels, we calculated the residuals from the association between
rs4731429 and cg00840332 using linear regression analyses. These residuals are no
longer affected by rs4731429 and can be used as independent variable to test interaction.
The residuals were then used in testing direct and interactive effects of DNA-M on leptin
levels.
4.2.2B F2 POPULATION
The methQTL analysis was replicated in the F2 population. Eighteen LEP SNPs
were genotyped in the F2 population but only 5 SNPs (rs2167270, rs2278815,
rs11760956, rs11763517, rs12706832) proved to have polymorphisms (the others were
monomorph, with all or almost all the population having one of the possible genotypes).
Haplotype analysis using Haploview software 125 revealed that SNPs rs2278815 and
rs12706832 were in LD with each other while rs11763517 and rs11760956 were in LD
with each other (Figure 4.1). Therefore, the methQTL analysis included the following
SNPs interacting with in utero smoking exposure predicting DNA methylation levels:
rs2278815, rs11763517, and rs2167270. While the SNPs in the F1 population were
collected via selected probes, a commercial genome wide product was used in the F2
population. This led to the following SNPs, rs2167270, rs2278815, rs11760956, and
rs12706832 not being identical with the SNPs identified in the F1 population. Hence, in
order to see if the findings in the F2 population are based on closely related SNPs, we
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generated a second LD plot using the International Haplotype Map (HapMap) project
data from the Central European University database 131 (Figure 4.2).

4.3 RESULTS
4.3.1 F1 GENERATION COHORT
Of the 1,152 participants from the whole birth cohort who had SNP data, 370 also
had DNA methylation data. There was no difference in the frequency of LEP SNP alleles
between the sub and whole populations (Table 4.1). There was also no difference in the
percentage of participants who were exposed to in utero smoking or in leptin levels at age
18. Because of interest of the parent study in the female line, more female participants
with DNA-methylations were selected for DNA-methylation analysis (66.2%). Girls had
higher leptin levels at age 18 (19.2 ng/mL) than boys (4.0 ng/mL, Table 4.1).
The four LEP SNPs in the F1 generation spanned the length of the leptin gene,
with one SNP in the flanking 5’UTR region, one in the intron region, and two in the
Flanking 3’UTR region (Table 4.3). LEP SNPs rs10249476 and rs11753517 were in
linkage disequilibrium with each other 128. Therefore, the models predicting DNA
methylation levels used the following SNPs: rs11763517, rs4731429, and rs10954176.
There were seven DNA methylation sites that were examined in the F1
generation, which were located at the start and end of the leptin gene, but none in the
middle of the gene (Table 4.4). All but two of the CpG sites presented high DNA
methylation levels (β-levels >0.90) while cg00840332 and cg00666422 showed low (βlevels: average 0.16) and medium (average 0.46) methylation, respectively (Table 4.4).
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In utero smoking exposure did not play a role in the association between LEP SNPs and
LEP DNA methylation levels.
Three CpG sites were observed to have methylation quantitative trait loci
(methQTL) (Table 4.5). Those with the AA and AG alleles of the rs4731429 SNP were
associated with a higher proportion of DNA methylation at the cg00666422 and
cg00840332 sites than those with the GG allele. Both the cg00840332 and cg00666422
methylation sites are located at the start of the LEP gene (TS200 CpG island and 5’UTR
region respectively, Table 4.4) while the rs4731429 SNP is located at the 3’UTR region
of the gene (Table 4.3a). Both of these methylation sites are also in cis association with
rs4731429 since they are less than 1Mb from each other 82, Tables 4.2 and 4.3. LEP SNP
rs4731429 also acted as a methQTL for cg24862443 (located at 3’UTR, Table 4.4), but
the association is in the opposite direction: those with the AA and AG genotype of the
SNP are associated with decreased proportion of methylation at that CpG site. The same
direction of association was observed for rs11763157, which was also a methQTL for
cg24862448. Sex only played a role in the cg00666422 methylation site. Boys had 0.17
higher proportion of methylation (β-levels) than girls at the cg00666422 methylation site
(Table 4.5). Because of the higher proportion of girls than boys in this subsample, sex
was weighted in the analysis.
One CpG site associated with a methQTL, cg00840332, was associated with
leptin levels at age 18 years. This association was modified by rs4731429, which was the
same SNPs that was a methQTL for the cg00840332 CpG site. Therefore, we calculated
the residuals from the association between rs4731429 and cg00840332, and used those
residuals in place of the cg0040332 in the model predicting leptin levels at age 18 (Table
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4.7). Among those with the AA genotype of the rs4731429 and rs11763517 SNPs,
increased methylation at cg00840332 was associated with decreased protein leptin levels
by 20.4ng/mL and 16.4 ng/mL respectively (Table 4.7).
4.3.2 REPLICATION ANALYSIS OF METHQTLS IN F2 POPULATION COHORT
Regarding the 419 children enrolled thus far in the F2 population cohort, cord
blood samples could not be collected from all children. Of the F2-children 139 also had
SNP data, and 125 people had SNP and DNA methylation data. There was no difference
in LEP SNP frequencies, sex, and in utero smoking exposure between the whole
population cohort and the children who had SNP data (Appendix B). There was also no
difference between the population with only SNP data and the population with SNP and
DNA methylation data (Appendix B). After removing monomorphic genetic markers (no
genetic polymorphisms), there were 5 LEP SNPs in the F2 population, with most of the
children having the heterozygous genotypes (Table 4.2). The SNPs in the F2 cohort
consisted of one in the exon region and the rest in the intron region of the gene (Table
4.3). Of these 5 SNPs, rs2278815 and rs1276832 were in linkage disequilibrium with
each other, rs11763517 and rs11760956 also were in linkage disequilibrium, (Figure 4.1).
Even though only one of the LEP SNPs (rs11763517) in the F2 generation was the same
as those analyzed in the F1 generation, other F2 and F1 SNPs were in linkage
disequilibrium with each other (Figure 4.2). Namely, rs4731429 and rs11760956 were in
the same haplotype block (Figure 4.2). Therefore, we could test whether we could
replicate the methQTL results found in the F1-generation. The results show that those
with the AA an AG genotypes of rs11760956 had a higher proportion of methylation at
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cg00840332 than those with the GG genotype. This mirrors the findings of rs4731429
being a methQTL for the same CpG site in the F1 population.

4.4 DISCUSSION
First, our findings show an association between LEP SNPs and DNA-methylation
in the F1-generation that could (partially) be replicated in the F2-generation. Those with
the AA and AG genotypes of the rs4731429 SNP were more susceptible to DNA
methylation at the cg00666422 and cg00840332 sites of the leptin gene (promoter regions
of the gene). Conversely, those with the AA and AG genotypes of the rs4731429 were
less susceptible to DNA methylation at the 3’UTR region of the gene, CpG site
cg24862443 (Table 4.5). The findings at the cg00840332 CpG site were replicated in the
subsequent generation (Table 4.6). As DNA methylation increased at the cg00840332
site, those with AA genotype of the rs11763517 SNP had lower leptin levels at age 18
(Table 4.7). Second, our results show that associations between genetic polymorphisms
and protein leptin levels are modified by LEP DNA methylation. The F2 population did
not have data on leptin levels, so the second part of the analysis could not be replicated in
the subsequent generation. When comparing models of SNPs and CPG sites predicting
protein leptin levels at age 18, SNPs and proportion of methylation indicate the same
level of fit (R2=0.17) while the SNP-CPG interaction model shows a slightly stronger fit
(R2=0.20).
It is unlikely that selection bias occurred in this study because the 370 participants
in the F1 cohort and the 125 participants in the F2 cohort were selected due to study
interests and do not deviate from their respective whole populations. For instance, there
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were no differences between the frequencies of LEP SNPs between the sample and whole
populations in both the F1 and F2 generations. There were also no differences in the
proportion of people who were exposed to in utero smoking. Using the Infinium Human
Methylation 450 array in the collection of DNA methylation data reduces the possibility
of information bias because it has strong reproducibility and validity 120,121.
As expected, leptin levels were higher in girls than boys at age 18 years (Table
4.1). However, this difference was not overwhelmingly reflected in DNA methylation
levels. We did not see a significant association when testing the interaction of SNPs and
sex on DNA methylation. Only one of the models for methQTL analysis showed that sex
had a significant effect on the association between LEP SNPs and LEP DNA
methylation: girls had lower DNA methylation at cg00840332 than boys. Hence, sex was
a confounder in the association between LEP DNA methylation and protein leptin levels,
but this association was not modified by sex. The investigated LEP SNPs are likely to be
representative of the leptin gene since they spanned the length of the gene (Table 4.3a)
and were in linkage disequilibrium with SNP data used in the International HapMap
project (Figure 4.2). However, the CpG sites used were mostly from the promotor region
of the region, with only one site at the 3’UTR region and no sites from coding on intron
regions of the gene (Table 4.4). It would be helpful for subsequent studies to investigate
the effects of DNA methylation on more regions of the LEP gene.

4.5 CONCLUSION
This study suggests that genetic variants of the LEP gene alter LEP DNA
methylation patterns in two consecutive generations, and that these methylation patterns
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in turn alter protein leptin levels in the F1 generation. Our findings show that SNPs and
DNA-M equally explain the variations in protein leptin levels but do not explain the
difference in leptin levels between boys and girls. When leptin binds to the leptin
receptor, it activates the Janus Kinas 2/Signal transducer and activator of transcription
(JAK2/STAT) pathway that leads to the release of cytokines involved in the body’s
immune response. A next step would be to investigate if there are other genes involved in
the JAK/STAT pathway and in protein leptin levels that could explain the differences
observed between boys and girls.
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Table 4.1. Population characteristics for F1 generation cohort
Sub population with DNA
methylation data

Whole cohort population with
SNP data

N=370
N (%)
76 (22.1)
174 (50.6)
94 (27.3)
49 (14.2)
177 (51.3)
119 (34.5)
93 (27.11)
164 (47.81)
86 (25.07)
76 (21.9)
179 (51.6)
92 (26.5)

N=1152
N (%)
238 (20.7)
582 (50.5)
332 (28.8)
156 (13.6)
542 (47.1)
453 (39.4)
338 (29.6)
534 (46.7)
271 (23.7)
293 (25.5)
569 (49.4)
289 (25.1)

N (Mean, Median; 5, 95%)

N (Mean, Median; 5, 95%)

P-Value

125 (33.8)
245 (66.2)

577 (50.1)
575 (49.9)

<.0000001

In utero smoking exposure (Yes)

75 (20.4)

266 (23.2)

0.26

Leptin at age 18 in boys (ng/mL)

120 (4.0, 1.2; 0.40, 16.0)

270 (4.0, 1.2; 0.40, 14.0)

Leptin at age 18 in girls (ng/mL)

239 (19.2, 13.1; 2.8, 54.6)

245 (18.7, 13.1; 2.4, 54.3)

SNP
rs4731429

rs10249476

rs10954176

rs11763517
62

Genotype
AA
AG
GG
AA
AC
CC
AA
AG
GG
AA
AG
GG

Variable
Sex

Male
Female

P-Value

0.50

0.19

0.50

0.25

Table 4.2. Population characteristics for F2 generation cohort

Sub population with SNP and DNA methylation data
N=125
SNP
rs2167270

rs2278815

rs11760956

rs11763517

rs12706832

Genotype
AA
AG
GG
AA
AG
GG
AA
AG
GG
AA
AG
GG
AA
AG
GG

Variable
Sex

Male
Female
In utero smoking exposure
No
Yes

N (%)
9 (7.2)
61 (48.8)
55 (44.0)
45 (36.0)
62 (49.6)
18(14.4)
9 (7.2)
63 (50.4)
53 (42.4)
34 (27.2)
64 (51.2)
27 (21.6)
18 (14.4)
62 (49.6)
45 (36.0)
N (%)
64 (51.2)
61 (48.8)
77 (64.2)
43 (35.8)
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Table 4.3. Location of LEP SNPs in F1 and F2 generation cohorts
F1 generation

F2 generation

SNP

Location

Chromosome: Coordinate

rs10249476

Flanking 5’UTR

7: 127877026

rs2167270

Exon

7: 127881349

rs11763517

Intron

7: 127890062

rs2278815

Intron

7: 127881851

rs4731429

Flanking 3’UTR

7: 127903539

rs12706832

Intron

7: 127887139

rs10954176

Flanking 3’UTR

7: 127907319

rs11763517

Intron

7: 127890062

rs11760956

Intron

7: 127891087

*Using coordinates from the GRCh37 assembly

SNP

Location

Chromosome: Coordinate
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Table 4.4. Distribution of DNA methylation of CPG sites on the LEP gene for F1 and F2 generations (β methylation levels)
F1 generation

F2 generation
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CpG site

Location

Chromosome:
Coordinate

N

Mean

5%

95%

N

Mean

5%

95%

cg14734794

TSS1500

7:127879921

370

0.96

0.95

0.97

125

0.92

0.90

0.95

cg00840332

TSS200

7:127881270

370

0.16

0.10

0.23

125

0.084

0.049

0.13

cg00666422

5'UTR

7:127881441

370

0.46

0.37

0.54

125

0.44

0.38

0.50

cg12083122

5'UTR

7:127883820

370

0.95

0.94

0.97

125

0.91

0.89

0.93

cg25435800

5'UTR

7:127890194

370

0.93

0.90

0.96

125

0.89

0.85

0.93

cg25730670

5'UTR

7:127891366

370

0.95

0.93

0.96

125

0.90

0.87

0.92

cg24862443

3'UTR

7:127896860

370

0.94

0.92

0.95

125

0.88

0.86

0.90

*Using coordinates from the GRCh37 assembly

Table 4.5. Methylation quantitative trait loci analysis for F1 generation cohort (M-values)
Variable

Estimate

T -test

F-test

P-value

P-value

FDR Adjusted
P-Value

0.10

0.10

0.005

0.006

0.00001

0.00005

0.007

N/A

0.005

0.006

0.0046

0.006

STD

Predicting methylation site: cg00666422*
rs11763517

rs4731429

(AA vs GG)

-0.12

0.06

0.036

(AG vs GG)

-0.05

0.05

0.24

(AA vs GG)

0.13

0.06

0.03

(AG vs GG)

0.14

0.04

0.001

Predicting methylation site: cg00840332
rs4731429

0.31

0.07

0.000002

(AG vs GG)

0.15

0.06

0.006

Male vs. Female

0.17

0.06

0.01
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(AA vs GG)

Sex

Predicting methylation site: cg24862443*
rs11763517

rs4731429

(AA vs GG)

-0.14

0.04

0.001

(AG vs GG)

-0.05

0.03

0.095

(AA vs GG)

-0.14

0.04

0.0014

(AG vs GG)

-0.08

0.03

0.01

*Models controlled for concentrations of the following cells: b cells, granulocytes, monocytes, natural killer cells,
eosinophils, and CD4t cells.

Table 4.6. Methylation quantitative trait loci analysis for F2 generation cohort (M-values)
Variable

Estimate

T -test

F-test

P-value

P-value

STD

Predicting methylation site: cg00666422*
rs11760956

(AA vs GG)

0.20

0.08

0.01

(AG vs GG)

0.13

0.06

0.02

(AA vs GG)

0.23

0.10

0.02

(AG vs GG)

0.17

0.05

0.002

0.03
rs2167270

0.006

Predicting methylation site: cg00840332*
67

rs11760956

(AA vs GG)

0.51

0.16

0.0019

(AG vs GG)

0.30

0.08

0.0004

0.0002

*Models controlled concentrations of the following cells: b cells, granulocytes, monocytes, natural killer cells, eosinophils, and CD4t
cells.
Note rs11760956 in the F2-generation and rs4731429 in the F1 generation are in linkage disequilibrium, presenting the same
haplotype block of the LEP gene.

Table 4.7. LEP DNA methylation predicting protein leptin levels (ng/mL) at age 18 in the F1 generation*
Estimate

Cg00840332**
rs11763517

Cg00840332** rs11763517

rs4731429
68
Cg00840332** rs4731429

Sex

STD

T- test

F-test

P-value

P-value

FDR Adjusted
P-value

11.3

8.3

0.18

0.016

N/A

7.7

3.7

0.04

0.11

N/A

AG vs GG 3.2

2.8

0.25

AA vs GG

-16.4

7.8

0.037
0.01

0.02

AG vs GG -0.20

6.8

0.98

7.7

3.6

0.03

0.07

N/A

AG vs GG 1.4

2.7

0.6

AA vs GG

-20.4

8.9

0.02
0.028

0.028

AG vs GG -14.7

5.9

0.01

2.4

<.0000001

AA vs GG

AA vs GG

Male vs. Female

-17.5

<.0000001 N/A

**This model is also controlled for the following cells: b cells, granulocytes, monocytes, natural killer cells,
eosinophils, and CD4t cells.
**We are using the residuals of DNA-methylation subtracting the effects of methQTL SNPs

Figure 4.1. Linkage disequilibrium plot of LEP SNPs in F2 cohort, D’ values
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Figure 4.2. Linkage disequilibrium plot of LEP SNPs from HapMap data
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CHAPTER 5
RESULTS III - MANUSCRIPT #3
LEPTIN ASSOCIATED WITH LUNG FUNCTION INDEPENDENT
OF BODY MASS INDEX3
5.1 INTRODUCTION
Historically leptin has been identified as regulator of appetite and energy expenditure
and is known for its relationship with obesity 1. However, over time it has been
established as a pleiotropic hormone that is responsible for many processes in the body 320,22,24

. Leptin was initially believed to be secreted only from adipose tissue, but in

consequent years it has also been detected in lower concentrations in peripheral lung
tissue in mice (bronchial epithelial cells, alveolar type II pneumocytes, and lung
macrophages) 174. Leptin is also thought to play a key role in lung maturation and to be a
stimulant of ventilation 29,31,38. In addition, the adipose tissue, initially believed to be
inert, is now known to be the site of release of numerous pro-inflammatory and antiinflammatory cytokines 28. Therefore, leptin is now considered to play a role in the
body’s host inflammatory response, both in relationship to adiposity and other
inflammatory pathways.
Given leptin’s involvement with inflammation, a few studies have investigated a
potential link between leptin and lung function. Studies in animals have suggested that
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independent of body mass index. To be submitted.
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leptin is involved in respiratory control. For example, when comparing mutant LEP mice
to their wild type counterparts and even before the onset of obesity, the mutant mice have
increased breathing frequency, minute ventilation and tidal volume, elevated PaCO2 and
depressed hypercapnic ventilatory response. Chronic leptin administration restores
breathing rates and improves lung compliance 30,32. However, because leptin
administration in mice also decreases weight, the improvement of breathing and lung
compliance cannot be conclusively attributed to leptin therapy and may not simply a
result of lowered body mass index (BMI). Acute leptin replacement, on the other hand,
has led to increased baseline ventilation independent of weight gain, and leptin injections
in rat brain has led to increased pulmonary ventilation and respiratory volume 29. Leptin
has also been observed to be involved in the regulation of embryonic lung growth and
maturation 106,117. Specifically, administration of leptin to antenatal mice has led to
improved lung development in the newborn 117, whereas leptin-deficient mice have been
observed to have impaired alveolar formation and lower lung volumes at birth 106.
Additionally, postnatal leptin treatment of these same mice has resulted in increased
alveolar surface area and lung volume 106.
Whereas the consensus in animal models is that higher leptin levels are correlated
with improved respiratory response, human studies yield either null findings or an inverse
association. Clinical studies have found that leptin is a predictor of lung function in
asthmatic children 35 and is negatively correlated to lung volumes in patients with chronic
obstructive pulmonary disease 118 and clinical severity of asthma 119. Van den Borst et al,
2012 observed no association between FEV1 and serum leptin levels but found that
increased serum leptin levels were associated with decreased FVC in men but not in
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women 52. There has also been an observed inverse association between serum leptin
levels and lung function in an African American population 89 and in a twin population 52.
Specifically, Hickson et al detected an inverse association between serum leptin levels
and predicted FEV1 and predicted FVC % independent of adiposity (total body weight,
waist circumference, and BMI) in an African American population women of a normal
body weight 89. The explanatory models were also adjusted for age, education, smoking
status, pack-years of cigarette smoking, respiratory medication use, and menopausal
status in women. Sin et al in a large sample (N=2808) also observed and inverse
association between serum leptin levels and FEV1 and FVC% predicted, independent of
adipocytes in men but found no such pattern in women 88. However, in a study involving
prepubertal boys and girls, increased leptin levels were associated with asthma only in
boys 48. In an Indian population, increased plasma leptin was associated with decreased
FEV1 but no association was found for FVC.
Although these studies suggest a role of leptin in lung function, their designs lack the
appropriate temporal sequence. The above-mentioned studies are cross-sectional or casecontrol studies and either focus on the stage of childhood or well into middle age. The
current study provided a longitudinal analysis addressing a time-order of exposure to
leptin with later measurements of lung function, particularly during the transition from
childhood to adulthood.
Using data from the Isle of Wight Birth Cohort, we tested the association of leptin at
ages 10 and 18 years with FVC, FEV1, and FEV1/FVC at ages 10 and 18 years. We tested
concurrent and effect-delayed models, controlling for BMI and analyzed boys and girls
separately.
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5.2 METHODS
5.2.1 POPULATION CHARACTERISTICS
A whole population birth cohort was established on the Isle of Wight, UK, in
1989 to prospectively study the natural history of allergies starting from birth. Ethics
approvals were obtained from the Isle of Wight Local Research Ethics Committee (now
the National Research Ethics Service Committee South Central – Southampton B). Of the
1,536 children born between January 1, 1989, and February 28, 1990, written informed
consent was obtained from parents to enroll 1,456 newborns. Children were followed up
at the ages of 1 (n=1,167), 2 (n=1,174), 4 (n=1,218), 10 (n=1,373), and 18 years
(n=1,313). The IOW birth cohort has been described in detail elsewhere 153. Detailed
interviews and examinations were completed for each child at each follow-up, including
BMI. When a visit was not possible, a telephone questionnaire was completed or a postal
questionnaire was sent. However, blood draw and the spirometric tests required that the
child visited the David Hide Asthma and Allergy Research Centre.

5.2.2 LEPTIN COLLECTION
Leptin concentrations were obtained from blood samples collected from at ages
10 and 18 years. Aliquots of blood serum isolated from the blood samples were used in
enzyme-linked immunosorbent assays from Biokit, S.A. (Barcelona, Spain). The assays
were conducted according to the manufacturer’s kit instructions. Each sample, including
standards and the blank, was assayed in duplicate. Leptin that was collected at age 10 was
analyzed in two different labs by two different investigators. Adjustments were made for
differences in scale of leptin values at age 10 between the two sets of measurements.
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Leptin levels that were collected at age 18 were determined by one of the same
investigator and same laboratory that collected leptin at age 10, providing some
consistency.

5.2.3 LUNG FUNCTION MEASUREMENTS
FVC and FEV1 were measured at ages 10 and 18 years. Lung function testing
was performed using the Koko spirometry software package on a portable desktop device
(PDS Instrumentation, Louisville, KY, USA) 154. Tests were performed in accordance
with American Thoracic Society and European Respiratory Society spirometry guidelines
175

. Children were required to be free from respiratory infection for 14 days and not

taking systemic oral steroids. In addition, subjects were asked to abstain from any betaagonist medication for at least 6 hours and from caffeine intake for at least 4 hours prior
to testing. Measurements were made in a standardized manner with the subject standing
without a nose clip 155. Forced vital capacity (FVC) was recorded in liters as the best of
three consecutive forced expiratory maneuvers. Participants that exhibited clinical
symptoms consistent with either current infection or a recent (within two weeks) asthma
exacerbation, which required antibiotics or oral steroid within the preceding two weeks,
were rescheduled for spirometry testing.

5.2.4 STATISTICAL ANALYSIS
Linear models were used the test the association between leptin and lung function
(FVC, FEV1, and FEV1/FVC). First, concurrent models tested the association between
leptin at age 10 and lung function at age 10 and leptin at age 10 and lung function at age
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18 years. Second, change in leptin levels from ages 10 to 18 were employed to predict
lung function at age 18 years (time-delayed model). Since prior findings suggested
variations of the associations by the sex of the child, boys and girls were analyzed
separately. In the concurrent models, we controlled for height and BMI at the respective
ages. In the delayed model, we controlled for height at age 18, change in height between
ages 10 and 18, and change in standardized BMI from ages 10 to 18.
Lastly, we tested the association between change in leptin levels interacting with
sex and lung function at age 18, stratifying the analysis by categorized BMI levels of low,
normal, and high. All analyses were done using SAS 9.4 (Gary, NC).

5.3 RESULTS
Of the 1,313 participants who were followed-up at age 18, 132 had data on leptin,
lung function, BMI, and height at ages 10 and 18 years. There was no statistical
difference between the cohort that followed up at age 18 and the sample of people that
were used in this study (Table 5.2). Girls had significantly higher levels of leptin at ages
10 and 18 years than boys (Table 5.1). Conversely, boys had significantly higher FVC
and FEV1 at both ages compared to girls. On average, between the ages of 10 and 18
years, leptin levels in boys increased by 1.3 ng/mL while that in girls increased by 12.9
ng/mL, this difference in change between the sexes was statistically significant. In some
boys, leptin levels dropped from ages 10 to 18. When investigating this change in leptin
levels throughout puberty and the relationship it could have on lung function at age 18,
we observed that the pattern in boys and girls was markedly different (Figure 5.1). In
boys, FVC and FEV1 were observed across a wide range while changes in leptin levels
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remained low, whereas in girls, FVC and FEV1 at age 18 remained the same across a
range of levels of change in leptin.
Controlling for BMI, concurrent models revealed that in boys, increased leptin
levels were associated with decreased FVC and FEV1 at age 10 (Table 5.3). A similar
pattern was observed in girls but only when analyzing the concurrent relationship
between leptin and FEV1 at age 10 (Table 5.3). No association was found between leptin
at age 10 and FEV1/FVC at age 10 in either boys or girls. In addition, concurrent models
at age 18 did not reveal any significant associations with leptin considering any of the
lung function measurements in boys or girls. This a cross-sectional analysis did not allow
for an evaluation of the time order between leptin and lung function.
Given the changes in leptin serum concentrations, to further investigate the time
order of exposure and effect, we tested whether there was an association between a
change in leptin levels (from ages 10 and 18) and lung function at age 18. In boys only,
for every 1 ng/mL increase in the change in leptin from age 10 to 18 years, FVC at age 18
decreased by 0.016 L. A similar pattern was observed in FEV1 in boys where, for every 1
ng/mL increase in the change in leptin from ages 10 to 18 years, FEV1 decreased by
0.014 L. (Table 5.4). No significant associations were detected in girls when testing the
association between change in leptin levels and lung function measurements at age 18.
The analysis of an interaction between change in leptin levels and sex with lung
function at age 18 revealed that in normal BMI only (N=234), for every 1 ng/mL
increased change in leptin between ages 10 and 18, boys had 0.02 L higher FEV1 at age
18 than girls.
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5.4 DISCUSSION
At age 10, our study shows an association between leptin and lung function that
exists even after controlling for body mass index (BMI). Both in boys and girls, increased
leptin levels were associated with decreased lung function. However, we observed
different patterns of leptin and lung function between boys and girls, both at ages 10 and
18 years. In girls, the increase in leptin between ages 10 and 18 was significantly higher
than the increase seen in boys (mean +1.3 in boys versus +12.9 in girls, p-Value:
<0.0000001). Conversely, boys had nearly double the increase in FVC (in liters)
following adolescence than girls (mean +3.0 in boys vs +1.7 in girls, p-Value:
<0.0000001). In boys only, the greater the increase in leptin between ages 10 and 18, the
lower FVC and FEV1 at age 18. Therefore, the change in leptin levels during puberty
(from age 10 to 18) was associated with FVC and FEV1 levels at age 18, controlling for
BMI and height changes. In those with normal BMI, boys who had a greater change in
leptin between ages 10 and 18 had 0.02 L higher FEV1 (P-value=0.03) than girls.
Of those participants who were followed-up at ages 10 and 18, data on lung
function measures, height, BMI, and leptin was available in a sample of 307 children.
There were no statistically significant differences in demographic and personal
characteristics between the sample population used in the analysis and the entire cohort
(Table 5.2), minimizing the possibility of selection bias in the study. When considering
the pubertal period between ages 10 and 18, we saw a significant association between the
change in leptin-sex interaction and lung function, only in normal weight participants
(N=234). However, the smaller sample size in the low (N=18) and high (N=47) BMI
groups may not have allowed identifying weaker associations. Trained physicians or
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nurses measured lung function, height, and weight, reducing the possibility of
information bias. There was a possibility of information bias when considering leptin
samples at age 10 because they were collected by two different investigators in different
laboratories. However, we standardized these values. In addition, after standardization,
we also controlled for the lab effect in all our models and found that it is did not have a
significant effect on our analysis.
Since leptin is involved in inflammatory pathways in the body, it would be helpful
to consider relevant cytokines that could play a role in the association between leptin and
lung function. It is thought that when leptin binds to the leptin receptor, a down-stream
JAK2/STAT pathway is activated 134-139,176-179 which results in the release of proinflammatory cytokines, such as Th1, TNF-α, IFN-γ, IL-2, IL-6, IL-12, and IL-10 86.
Among these cytokines, we had collected IL-10 and IL-12 in our study, and we tested
their association with FVC, FEV1, and FEV1/FVC at ages 10 and 18 with null results
(Appendix C and D).
In other studies, it has been observed that testosterone inhibits the expression of
leptin in the body while ovarian sex steroids have the opposite effect 55,59,60. This is
supported by our data that shows significantly higher leptin levels in girls at both ages, as
well as a significantly higher increase between ages in girls compared the change
observed in boys (Table 5.1). Since we did not have data on sex steroid levels in our
participants we used the proxy measure of controlling for pubertal events in our models.
These pubertal events included ages of onset of breast growth and menarche in girls, age
of growth spurt in boys, average age of pubertal onset, and duration of onset of pubertal
events. Detailed information on these variables can be found in a previous puberty study
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by our team 153. We found that none of the pubertal events were significant in any of our
models.

5.5. CONCLUSION
The role of leptin in lung function is still not completely clear and the different
trends observed in boys and girls has not been explained. Although notable changes occur
in leptin and lung function level during the transition between childhood to adulthood,
looking at the onset of pubertal events does not explain the associations observed
between these two factors. It would be important to explore more direct variables, such as
sex steroid levels or relevant genes that play a role in sex steroid synthesis. Furthermore,
other cytokines that are more closely related to leptin, such as IL-6, should be evaluated.
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Table 5.1 Population characteristics
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Leptin at age 10 (ng/mL)
Leptin at age 18 (ng/mL)
Change in leptin
between ages 10 and 18 (ng/mL)
Height at age 10 (cm)
Height at age 18 (cm)
Change in height
between ages 10 and 18 (cm)
Forced vital capacity
(FVC) at age 10 (L)
FVC at age 18 (L)
Change in FVC
between ages 10 and 18 (L)
Forced expiratory volume in one
second (FEV1) at age 10 (L)
FEV1 (L) at age 18
Change in FEV1
between ages 10 and 18 (L)
FEV1/FVC at age 10
FEV1/FVC at age 18
Change in FEV1/FVC
between ages 10 and 18
Standardized BMI at age 10 (kg/m2)
Standardized BMI at age 18 (kg/m2)
Change in standardized BMI
between ages 10 and 18 (kg/m2)

N
150
288
145

Mean
3.19
3.99
1.3

Male
Median
1.55
1.22
0

p5, p95
0.4, 12.2
0.4, 13.1
-3.9, 10.0

N
246
265
174

Mean
8.2
18.9
12.9

Female
Median
4.2
13.1
9.3

488
395
391

2.35
5.3
38.9

2.33
5.3
39.0

1.8, 2.9
4.2, 6.6
31.6, 46.5

493
443
436

2.2
4.0
25.7

2.2
4.0
26.2

488

2.35

2.33

1.8, 2.9

493

2.2

395
326

5.3
3.0

5.3
3.0

4.2, 6.6
2.1, 3.9

443
372

488

2.06

2.04

1.6, 2.6

396
327

4.62
2.5

4.55
2.5

3.6, 5.6
1.9, 3.2

488
396
327

0.88
0.87
-0.01

0.88
0.87
-0.01

516
465
382

-0.2
-0.2
0.03

-0.4
-0.3
0.05

P-value
<.0000001
<.0000001
<.0000001

2.2

p5, p95
0.6, 29.2
2.4, 54.6
-4.0,
44.8
1.7, 2.8
3.1, 4.8
15.8,
33.9
1.7, 2.8

4.0
1.7

4.0
1.7

3.1, 4.8
1.1, 2.4

<.0000001
<.0000001

492

2.00

2.00

1.6, 2.5

0.0011217

443
372

3.47
1.5

3.48
1.5

2.7, 4.2
0.9, 2.0

<.0000001
<.0000001

0.8, 0.97
492
0.7, 0.98
443
-0.01, 0.09 372

0.90
0.88
-0.02

0.90
0.88
-0.01

0.0000003
0.0060977
0.2687622

-1.2, 1.6
527
-1.2, 1.6
499
-1.28, 1.15 424

0.19
0.15
0.03

-0.05
-0.08
0.10

0.8, 0.98
0.8, 0.98
-0.1,
0.07
-1.1, 2.4
-1.1, 2.4
-1.2, 1.3

0.8099200
<.0000001
<.0000001
<.0000001

<.0000001
0.0000005
0.9143892

Table 5.2 Population Characteristics in sample and whole cohort at age 18

N

Cohort at age 18 follow up
Mean
Median P5, P95

N

Sample used in analysis
Mean Median
P5, P95

Leptin at age 18 (ng/mL)

553

11.12

4.92

0.40, 43.0

317

12.65 6.78

FVC at age 18 (L)
FEV1 at age 18 (L)
FEV1/FVC at age 18
Standardized BMI at age 18 (kg/m2)
Height at age 18 (cm)

838
839
839
964
994

4.61
4.01
0.87
5.6E-15
171.2

4.47
3.91
0.88
-0.24
171.0

3.22, 6.28
2.85, 5.41
0.75, 0.98
-1.15, 2.07
156.5,
187.0

307
308
308
317
317

4.66
4.07
0.88
0.09
171.0

N
144
173

%
45.4
54.6

Female
82

N
Male 786
Female 750

%
51.17
48.83

4.46
3.97
0.88
-0.17
171.0

0.40,
48.96
3.34, 6.41
3.01, 5.42
0.76, 0.98
-1.03, 2.24
156.0,
186.0
P-Value

PValue
0.25
0.44
0.25
0.54
0.21
0.83

0.60

Table 5.3 Concurrent models at age 10 years in girls and boys
Variable

Estimate
STD
FVC at age 10 in BOYS (Liters)
Leptin at age 10 (ng/mL)
-0.016
0.007
2
Standardized BMI at age 10 (kg/m )
0.077
0.041
Height at age 10 (cm)
0.038
0.004
FEV1 at age 10 in BOYS (Liters)
Leptin at age 10 (ng/mL)
-0.014
0.006
2
Standardized BMI at age 10 (kg/m )
0.048
0.037
Height at age 10 (cm)
0.030
0.003
FEV1 at age 10 in GIRLS (Liters)
Leptin at age 10 (ng/mL)
-0.005
0.002
Standardized BMI at age 10 (kg/m2)
0.050
0.020
Height at age 10 (cm)
0.032
0.002

83

P-Value
0.02
0.07
<.0000001
0.03
0.20
<.0000001
0.02
0.013
<.0000001

Table 5.4. Change in leptin levels between ages 10 to 18 predicting FVC and FEV1 at
age 18 years in girls and boys
Variable

Estimate
STD
FVC at age 18 in BOYS (Liters)
Change in leptin from ages 10 to 18
-0.017
0.0072
years (ng/mL)
Change in standardized BMI from
0.402
0.095
ages 10 to 18 years (kg/m2)
Change in height from ages 10 to 18
-0.025
0.014
years (cm)
Height at age 18 (cm)
0.071
0.009
FEV1 at age 18 in GIRLS (Liters)
Change in leptin from ages 10 to 18
-0.013
0.0060
years (ng/mL)
Change in standardized BMI from
0.235
0.079
2
ages 10 to 18 years (kg/m )
Change in height from ages 10 to 18
-0.021
0.012
years (cm)
Height at age 18 (cm)
0.063
0.0074

84

P-Value
0.018
0.000045
0.082
<0.0000001
0.029
0.0037
0.069
<0.0000001

Table 5.5 Interaction of change in leptin levels between 10 and 18 years with sex
associated with FEV1 at age 18, stratified by low, normal, and high BMI categories
Variable

Estimate
BMI=low; N=18
Delta Leptin(ng/mL)1
0.01
Sex (Male vs Female)
1.20
Delta Leptin (ng/mL) * sex (Male vs Female)
-0.13
Delta Height2 (cm)
-0.04
Height at age 18 (cm)
0.03
BMI=normal; N=234
Delta Leptin(ng/mL)1
-0.003
Sex (Male vs Female)
0.63
Delta Leptin (ng/mL) * sex (Male vs Female)
0.02
2
Delta Height (cm)
-0.009
Height at age 18 (cm)
0.05
BMI=high; N=47
Delta Leptin(ng/mL)1
-0.005
Sex (Male vs Female)
0.38
Delta Leptin (ng/mL) * sex (Male vs Female)
-0.007
Delta Height2 (cm)
-0.006
Height at age 18 (cm)
0.049
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STD

P-Value

0.05
0.40
0.09
0.03
0.02

0.83
0.01
0.16
0.16
0.17

0.004
0.35
0.10 <0.0000001
0.009
0.03
0.007
0.19
0.005 <0.0000001
0.004
0.24
0.007
0.01
0.008

0.18
0.13
0.30
0.63
0.0000006

Figure 5.1. Lung function versus the difference in leptin levels between ages 10 and 18
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CHAPTER 6
CONCLUSION AND FINAL REMARKS
This dissertation contributes to knowledge of the role of leptin in the body’s host
inflammatory response by showing an association between LEPR SNPs and lung
function, and presenting a possible mechanism of this association. We found that LEPR
SNPs were associated with decreased FVC, FEV1 and FEV1/FVC in a repeated
measurement analysis (SA1). Using data from the F1 generation Isle of Wight birth
cohort, we then demonstrated a two-stage model of epigenetic analysis (SA2) by first
identifying methQTLs in the association between LEP SNPs and LEP DNA methylation
and second, finding an association between an LEP CpG sites (that were identified in
stage 1) and serum leptin levels. We replicated the stage 1 findings in the F2 generation
cohort. Lastly, we found that increases in leptin levels from ages 10 to 18 were associated
with decreased lung function in boys as girls; and that in those with normal BMI, boys
who had a greater change in leptin between the ages of 10 and 18 years had a higher
FEV1 than girls (SA3).

6.1 SUMMARY OF AIM 1
Our longitudinal analysis of repeated measurements of FVC, FEV1, and
FEV1/FVC identified one LEPROT and two LEPR SNPs that were associated with lung
function, while reporting no significant associations between lung function and LEP
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SNPs. To our knowledge, we were the first to explore the longitudinal association
between LEP SNPs (rs10249476, rs11763517, rs4731429, and rs10954176) and FVC,
FEV1, FEV1/FVC. More studies need to be conducted on LEP SNPs (the ones used in
this study as well as other genetic variations) for comprehensive understanding of the role
of LEP and LEPR SNPs.
Regarding LEPR SNPs, the CC genotype of rs6669354 was associated with
decreased FVC and FEV1 when compared to the AA genotype. Similarly, the AA
genotype of rs1137101 was associated with decreased FEV1/FVC when compared to the
GG genotype. Despite leptin and lung function values being significantly different
between boys and girls, especially the change between ages 10 and 18 years, we did not
find that sex modified the relationship of these SNPs with lung function. We also did not
find that the child ever smoking or breastfeeding duration modified the relationship.
A potential shortcoming in looking at LEPR SNPs is that we cannot known what
splicing will occur. Of the leptin receptor’s six isoforms, it is the long form for the leptin
receptor, LEPRb, that circulating leptin binds to which starts the inflammatory pathway
that can lead to airway obstruction. Therefore, it may be more useful to investigate the
leptin receptor protein. In addition, there are other genes that could influence leptin’s
relationship with lung function.

6.2 SUMMARY OF AIM 2
We used the two-stage epigenetic model of analysis to first identify methQTLs
(specifically LEP SNPs rs11763517 and rs4731429 associated with LEP DNA
methylation) and second to test whether LEP DNA methylation and serum leptin levels at
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age 18 were associated. We did not find an interaction between maternal smoking during
pregnancy and LEP SNPs in predicting DNA methylation levels. We successfully
replicated our methQTL analysis in the F2 population cohort. Specifically, we found that
in the F1 population, LEP SNP rs4731429 was associated with increased DNA-M at
cg00666422 and cg00840332 and decreased DNA-M at cg24862443 on the LEP gene;
rs11763517 was associated with decreased DNA-M at the cg24862443 site. In the F2
population, rs11760956 (in LD with rs4731429) is associated with increased DNA
methylation at cg00666422 and cg00840332.
Given that the leptin receptor is a requirement for the initiation of inflammatory
pathways involving leptin, a necessary next step is to further investigate the leptin
receptor protein as well as LEPR DNA methylation. It would also be interesting to see
how the leptin receptor and leptin proteins and genes interact with each other in these
associations.

6.3 SUMMARY OF AIM 3
We found that in both boys and girls, the higher the increase in leptin serum
concentrations between ages 10 and 18, the lower the lung function measurements. In
those with normal BMI, for every one ng/mL increase in the change in leptin between
ages 10 and 18, boys had 0.02 L higher FEV1 than girls. Investigating at both ages 10 and
18, we did not find any associations between cytokines IL-10 and IL-12 with FVC, FEV1,
or FEV1/FVC. Regarding pulmonary function, we observed that the increase in FVC and
FEV1 between ages 10 and 18 in boys nearly doubled compared to the increase in girls.
Conversely, leptin increased in girls between those ages at much higher rates that than
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observed in boys. These differential changes that occur during the pubertal transition
suggest that puberty may play a role in this difference between the sexes. Furthermore,
testosterone is known to suppress leptin while ovarian sex hormones are associated with
increased leptin. However, when testing markers of puberty onset in our dataset (such as
the age of onset of menarche or the age of onset of growth spurt), we found no
associations in our models. We were not able to explain this difference between boys and
girls. Improved markers for pubertal changes, such as levels of sex steroid hormones, or
additional genetic markers may provide further insights.
We successfully demonstrated an association between leptin protein and lung
function measurements that existed even after adjusting for BMI. However, although
leptin is associated with obesity, BMI is not the most accurate approximation of
adiposity. Nevertheless, future studies should investigate whether co-variation of BMI
and leptin may be improved when using other variables for adiposity. In addition, we
only had two cytokines (IL-10 and IL-12) in our dataset that were relevant to leptin and
the body’s immune response. When looking at the relationship between leptin and lung
function, the association could be mediated by other cytokines that are more directly
related to this inflammatory process. A few relevant cytokines to be considered are IL-1β,
IL-6, IL-8, IL-12, TNF-α, and TNF-γ. Lastly, when looking at the protein-to-lung
function association, the leptin receptor protein must also be included. There could be a
more direct relationship between concentrations of LEPRb (the long isoform of the leptin
receptor) and lung function measures.
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6.4 FINAL REMARKS
Leptin clearly plays a role in inflammation and is associated with lung function,
but this association still needs to be better explored. Our longitudinal analysis of SNPs
and lung function revealed that LEPR SNPs (but not LEP SNPs) were associated with
FVC, FEV1, and FEV1/FVC. Therefore, the leptin receptor may play a more prominent
role in lung function than leptin and more studies should consider the leptin receptor
protein when investigating leptin’s relationship with lung function and obstructive
pulmonary diseases. When possible, studies should specifically look at the longform of
the leptin receptor (LEPRb) because it is that isoform that, when bound to the leptin
protein, is involved with the JAK/STAT pathway.
A weakness of our study could be that we only had data on four LEP SNPs,
although these SNPs did span the length of the leptin gene. In our data CpG sites on the
leptin gene were mostly located in the promoter region, with only one in the 3’ UTR
region and none in the coding or intron regions. It might be illuminating to perform the 2stage analysis demonstrated in SA2 with different LEP SNPs and CpG sites. We also did
not have data on cytokines that were more closely linked to leptin or lung function, which
prevented us from doing a path analysis in SA3 (testing the theoretical path of protein
leptincytokinelung function measurement). Lastly, there was a possibility of
information bias in the collection of leptin levels at age 10 since the values were collected
by two different investigators in two different labs. However, we corrected for this by
standardizing the leptin values and controlling for the different labs in the models.
A strength of this dissertation is that in all three specific aims, the possibility of
selection bias was unlikely. In addition, the reproducibility and validity of our DNA
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methylation data was superior to other methods, and we successfully replicated our
methQTL analysis of the F1 population in the F2 generation cohort (SA2). We found an
association between LEPR SNPs and lung function and presented a potential mechanism
for this association via LEP DNA methylation and serum leptin protein.
A consistent theme throughout this dissertation was the importance of considering
boys and girls separately when looking at leptin and lung function (and by extension,
other pulmonary disorders). Although we could not explain the differences between boys
and girls in leptin and lung function levels at the genetic level, we did see a difference
between boys and girls when investigating the interaction effect of change in leptin and
sex on lung function at age 18. More studies need to investigate the mechanism behind
these observed changes so that potential clinical attempts to treat suboptimal lung
function with leptin administration can consider differentiated dosages based on sex.
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APPENDIX A
ASSOCIATION OF LEP, LEPR, AND LEPROT SNPS
WITH BMI AT AGES 10 AND 18 YEARS
Table A.1
BMI age 10
(P-value)
LEPrs4731429
0.0102
LEPrs10249476
0.0166
LEPrs10954176
0.4254
LEPrs11763517
0.0327
LEPRrs3806318
0.5306
LEPROTrs17412175 0.3387
LEPRrs7526141
0.3480
LEPRrs1137101
0.6604
LEPROTrs9436740 0.0518
LEPROTrs9436301 0.2881
LEPROTrs6669354 0.3264
LEPRrs12059300
0.4537
LEPRrs3762274
0.6499
LEPRrs8179183
0.2096
SNP
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BMI age 18
(P-value)
0.0892
0.3117
0.3054
0.7317
0.5477
0.3867
0.9443
0.8446
0.2136
0.1414
0.2773
0.9881
0.1330
0.6693

APPENDIX B
POPULATION CHARACTERISTICS IN F2 COHORT
Table B.1
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APPENDIX C
BOYS: SPEARMAN CORRELATIONS OF LEPTIN AND LUNG FUNCTION VALUES AT
AGES 10 AND 18 WITH IL-10 AND IL-12 AT AGES 10 AND 18
Table C.1
ρ
P-value
N
IL10 at age 10
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IL10 at age 18

IL12 at age 10

IL12 at age 18

Leptin at
age 10

Leptin at
age 18

FVC at
age 10

FVC at
age 18

FEV1 at
age 10

FEV1 at
age 18

FEV1/FVC FEV1/FVC
at age 10
at age 18

0.08889
0.3816
99
0.06051
0.5437
103
-0.01374
0.8926
99
0.02876
0.7730
103

-0.03494
0.6989
125
-0.00604
0.9348
186
-0.03137
0.7284
125
0.00681
0.9265
186

-0.11012
0.2273
122
-0.00810
0.9201
156
-0.10226
0.2624
122
-0.15366
0.0555
156

0.03311
0.7129
126
0.01669
0.8246
179
0.09142
0.3086
126
-0.11231
0.1344
179

-0.10069
0.2698
122
-0.00306
0.9698
156
-0.01880
0.8371
122
-0.14123
0.0786
156

0.09228
0.3041
126
0.01518
0.8397
180
0.15777
0.0777
126
-0.09637
0.1981
180

-0.01514
0.8685
122
-0.01733
0.8299
156
0.18853
0.0376
122
0.02054
0.7991
156

0.04649
0.6052
126
-0.07470
0.3189
180
0.11286
0.2083
126
0.00484
0.9486
180

APPENDIX D
GIRLS: SPEARMAN CORRELATIONS OF LEPTIN AND LUNG FUNCTION VALUES AT
AGES 10 AND 18 WITH IL-10 AND IL-12 AT AGES 10 AND 18
Table D.1
ρ
P-value
N
IL10 at age 10
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IL10 at age 18

IL12 at age 10

IL12 at age 18

Leptin at
age 10

Leptin at
age 18

FVC at
age 10

FVC at
age 18

FEV1 at
age 10

FEV1 at
age 18

FEV1/FVC FEV1/FVC
at age 10
at age 18

0.03127
0.7292
125
0.02250
0.7911
141
0.08109
0.3687
125
-0.05995
0.4801
141

0.18895
0.0238
143
0.04611
0.5136
203
0.05273
0.5317
143
0.00836
0.9058
203

0.03754
0.6597
140
0.01695
0.8233
176
-0.00614
0.9426
140
0.04535
0.5500
176

-0.05066
0.5479
143
0.08449
0.2319
202
-0.02898
0.7311
143
0.10146
0.1508
202

0.01062
0.9009
140
-0.02361
0.7557
176
0.00938
0.9124
140
0.09102
0.2296
176

-0.02968
0.7249
143
0.10732
0.1284
202
-0.03221
0.7025
143
0.18607
0.0080
202

-0.06265
0.4621
140
-0.09080
0.2307
176
-0.00237
0.9779
140
0.06606
0.3837
176

0.09196
0.2747
143
0.02745
0.6981
202
0.04518
0.5921
143
0.09727
0.1685
202

